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Abstract 
Successful delivery of drug molecules and therapeutic genetic materials across the 
plasma membrane into the target cells in sufficient dosage is important for satisfactory 
treatment effects. Ultrasound excitation of microbubbles generates disruption of the cell 
membrane (sonoporation) and opens new opportunities for non-viral intracellular drug 
and gene delivery. When excited by ultrasound, microbubbles undergo rapid volume 
expansion and contraction as well as collapse (cavitation) and can temporally disrupt the 
cell membrane, creating a direct physical route for the transport of extracellular agents 
into viable cells. However, despite increasing interest and recent progresses, challenges 
and difficulties remain to be overcome, including relatively low delivery efficiency and 
large variation in delivery outcomes. These difficulties are mainly due to the insufficient 
understanding of the underlying mechanisms and process of sonoporation. This study 
aims to obtain a comprehensive understanding of sonoporation mechanisms and process  
under well controlled environments. We employed various strategies to precisely control 
microbubbles location and cavitation, using fast-frame bright field video-microscopy 
combined with real-time fluorescence microscopy to reveal ultrasound excited 
microbubble dynamics and subsequent cellular responses, such as membrane rupture, 
calcium transient and waves, and gene transfection. The specific aims of this study are: 1) 
to investigate the intracellular transport and calcium transient generated by sonoporation; 
2) to exploit dynamics activities of microbubbles driven by ultrasound and correlate with 
xv 
 
delivery outcomes; 3) to achieve controlled and enhanced delivery outcomes facilitated 
by targeted microbubbles. 
1 
 
 
 
 
 
 
Chapter 1  
Introduction 
Successful delivery of drug molecules and therapeutic genetic materials across the 
plasma membrane into the target cells in sufficient dosage is important for satisfactory 
treatment effects [1, 2]. Sonoporation, or ultrasound generated disruption of the cell 
membrane, has been exploited as a new strategy for non-viral intracellular drug and gene 
delivery [3-10]. However, despite increasing interest and progresses made recently, 
challenges and difficulties remain to be overcome, including relatively low delivery 
efficiency and large variation in delivery outcomes [11].  
The objective of this study is to develop sonoporation as a controlled and highly 
efficient intracellular delivery technique based on a comprehensive understanding of 
sonoporation process and mechanisms under controlled environments. The mechanic 
impact of ultrasound excited microbubble exerted on the nearby cells has been 
recognized to be the cause for the reversible increase of the cell membrane permeability 
(sonoporation) [12-14], allowing entry of extracellular therapeutic agents into the cells 
through temporally disrupted regions on the membrane [15-17]. Microbubble-facilitated 
sonoporation has demonstrated great potential as an efficient, non-invasive and targeted 
delivery method for many in vitro and in vivo applications [3-7], although difficulties and 
challenges remain to be overcome.  
 
 
2 
 
1.1 Specific aims 
Transportation of drug molecule and therapeutic genetic materials across the 
plasma cell membrane is highly significant and an important area of pursuit in basic 
biological and medical research. Various approaches have been exploited [12, 18-21]; yet 
robust intracellular delivery of these bio-molecules still remains a major challenge. 
Sonoporation is the ultrasound generated poration of cell membrane [15, 22, 23]. The 
physical disruption of cell membrane by ultrasound, often facilitated by microbubbles, 
creates a direct physical route for the transport of extracellular membrane impermeable 
compounds into the cytoplasm of viable cells, thereby making microbubble-facilitated 
sonoporation a promising technique for intracellular delivery of therapeutic agents.  
Even with recent progress in the field, however, many difficulties still remain that 
hinder the practical translation of sonoporation technology into a viable and robust 
strategy. Sonoporation currently has relatively low delivery efficiency compared with 
other techniques such as viral vector transfection, and large variation exists in the 
delivery outcomes [11]. These difficulties are largely due to the lack of knowledge about 
sonoporation occurrence and its subsequent bioeffects. Therefore, it is of great 
importance to elucidate microbubble activities on the cell membrane and cellular 
responses to reveal the underlying mechanisms. Static post-ultrasound assessment 
methods that many conventional sonoporation studies employed, may not be suitable for 
investigating the inherently dynamic and transient process of sonoporation, because no 
detailed information is available to directly relate the microbubble-cell interaction with 
sonoporation outcomes.  
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In this study, we aim to investigate the underlying mechanisms and processes of 
sonoporation and the relevant consequences at cellular level in order to achieve 
controlled and improved drug and gene delivery outcomes. Designed to address the key 
questions in order to obtain improved understanding of the mechanisms of sonoporation, 
the specific aims of this research are: 
Aim 1: To investigate intracellular transport and calcium transients generated by 
sonoporation facilitated by non-targeted microbubble; 
Aim 2: To study the dynamic activities of non-targeted microbubbles driven by 
ultrasound and correlate with delivery outcomes;  
Aim 3: To achieve controlled and improved delivery outcomes facilitated by targeted 
microbubbles. 
These three aims will be described and discussed in details in chapters 2 – 4. To 
address the specific aims, we developed a research design that employs various strategies 
to control microbubbles location and activities to establish controlled experimental 
environments. Fast-frame bright field video-microscopy synchronized with ultrasound 
application was employed to monitor the microbubble activities upon ultrasound 
stimulation; while real-time fluorescence microscopy was applied to assess membrane 
rupture, intracellular calcium transient and waves, and gene transfection. By 
spatiotemporally correlating the bubble dynamics with these biological consequences, we 
characterized the transient processes of pore formation, studied microbubble dynamics 
under various ultrasound conditions, and finally utilized this knowledge to achieve 
controlled and improved delivery outcomes. 
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1.2 Background  
1.2.1 Current techniques for intracellular drug and gene delivery 
Identification of molecular mechanisms responsible for diseases and the synthesis 
of new drug or genetic strategies alone cannot guarantee efficient therapy. Successful 
delivery of therapeutic agents to the designated target cells and even sub-cellular sites of 
action with sufficient dosage is essential to achieve satisfactory treatment effects [1, 2]. 
Conventional drug delivery methods, such as intravenous injection and oral 
administration, are not suitable for highly toxic anticancer drugs or recombinant DNAs 
for gene therapy, as all healthy tissues and organs are undesirably exposed to the drugs 
and genes. There has been an upsurge of global interests in developing targeted delivery 
techniques, in order to increase drug and gene delivery efficacy as well as to minimize 
any side effects [7, 12, 20, 24]. Although targeted delivery shows great potential, it faces 
serious technical challenges due to many diffusional and metabolic fences on the delivery 
pathway [25]. One major difficulty is to facilitate therapeutic agents transport across 
plasma cell membrane. Another barrier is the nuclear membrane, in the case of gene 
delivery, as well as antibody and drugs whose targeted action sites are located in cell 
nuclei [25-27]. 
As a special case of drug delivery, gene delivery is an emerging therapeutic 
strategy that offers the promise of treating a wide variety of inherited and acquired 
diseases by genetic modification of cells or production of therapeutic proteins within cells 
[18, 27, 28]. Most genetic molecules are both large and negatively charged, making it 
difficult for them to spontaneously transpass the negatively charged and relatively 
lipophilic plasma membrane [27]. Therefore, assisting delivery reagents or external 
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energy deposit has been exploited to facilitate gene transportation across the cell 
membrane. Gene transfection techniques may be divided into two categories: viral and 
non-viral. Viral vectors take use of the millions-of-years naturally evolved ability of virus 
to efficiently transfer genetic material of their own into host cells. The viral vectors, in 
general, are superior to their non-viral counterparts [21, 29]. Viral vectors derived from 
retroviruses, adenovirus, adeno-associated virus, herpesvirus and poxvirus are actively 
employed both at the level of laboratory developments and of clinical applications [21, 
29]. Despite the remarkable efficacy in gene transfection, the possibility of viral vector to 
evoke inflammatory and adverse immunogenic responses and to produce insertional 
mutagenesis limits its translation from preclinical studies to human treatment [30, 31].  
In contrast, non-viral gene delivery methods possess many important safety 
advantages, therefore attracting increasing attention, although transfection efficiency is 
still far from being ideal [18, 32]. In non-viral gene transfection, genetic materials exist in 
the format of plasmid vectors, which are composed entirely of covalently closed circles 
of double-stranded DNA [33]. To aid entry of plasmids into cells, transfection reagent 
molecules and/or physical energy is often required. The materials currently used as non-
viral gene transfection reagents include cationic and neutral lipids, cationic polymers, 
peptides or combination thereof [28, 34]. The most commonly used is cationic liposome 
(microscopic vesicles of amphiphilic molecules surrounding a watery interior) mediated 
gene transfer, often termed as lipofection [35-37]. Due to the similarity to plasma cell 
membrane, liposome exhibits high biocompatibility. Cationic liposomes form a complex 
with negatively charged DNA molecules (known as “lipoplex”) with a small net positive 
charge, which can be electrostatic attracted by the negatively charged cell membrane. 
6 
 
While the process of DNA attachment onto the cell membrane is rapid, the trafficking of 
plasmid DNA inside the cell toward nucleus is generally slow (hours), as plasmid DNA 
has to escape from endosome after endocytosis, migrate toward nucleus, and traverse 
nuclear envelop [38-40]. Along the way, the foreign DNA could be partially degraded by 
cytoplamic DNases or by the acidic environment in late endosome or lysosome [34, 38, 
40, 41]. The nuclear membrane barriers, DNases metabolism and endosome environment, 
etc. vary dramatically among different cell types, which may explain the large variation 
of transfection efficiency by lipofection in different cell types.  
A number of physical approaches, as an alternative to viruses or transfection 
reagents, have been demonstrated to enhance plasmid delivery by temporarily increasing 
the permeability of cell membrane. Physical methods include microinjection, 
magnetofection, laser poration, ballistic delivery, hydrodynamic delivery, electroporation 
and ultrasound mediated delivery (sonoporation) [42-44]. Electroporation and 
microbubble-mediated ultrasound are two of the most effective physical methods that can 
be applied both in vitro and in vivo. Electroporation is an established technique to 
introduce DNA or other molecules into cells by transiently increasing cell membrane 
permeability using a high electric field [45-48]. The creation of aqueous pores is believed 
to be the cause of increased permeability in electroporation [45-48]. The size of these 
membrane openings in red blood was reported to be between 20 nm-120 nm [49]. The 
precise dynamic details of cell membrane change during electroporation are still elusive. 
It has been suggested that small molecules, such as anticancer drugs, can enter cells via 
simple diffusion through pores induced by strong electrical fields; while macromolecules, 
such as DNA, enter cells through a more complex interaction with cell membrane, 
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involving the electrophoretically driven interaction of the DNA molecules with the 
destabilized membrane during the electric pulses and then their passage across the 
membrane [19]. Many factors have effects on transport efficiency in electroporation, 
including electrodes configurations, pulse patterns, pulse magnitude, and duration etc. It’s 
reported that short pulses (100 μs) of high electric field strength (>700 V/cm) is optimal 
for small anti-cancer drug delivery, whereas longer pulses (20-60 ms) with lower field 
strength (100-200 V/cm) were preferred for gene transfer [50, 51].  
1.2.2 Therapeutic application of ultrasound combined with microbubbles 
Ultrasound technology is spreading its medical application from diagnostic 
imaging to medical therapy. This change is coupled with the advent and development of 
engineered gas bubbles. First introduced as an ultrasound imaging contrast enhancement 
agents, microbubbles have shown great potential for their therapeutic application recently 
[12, 52, 53]. Although the mechanisms of ultrasound microbubble mediated delivery is 
not yet fully understood, cavitation of microbubbles by ultrasound excitation is most 
likely to be the cause for reversibly increase of the cell membrane permeability, often 
termed as sonoporation [54-56]. Many studies have examined the improved effect of 
ultrasound microbubble mediated delivery, including delivery of drugs [57-60], antibody 
[61] peptide [62, 63], siRNA [8-10], and DNA plasmid [64-68] both in vitro and in vivo. 
However, currently sonoporation has, in general, low delivery efficiency compared with 
viral techniques as well as other non-viral techniques such as lipofection and 
electroporation [11, 40]. Understanding the fundamental mechanisms involved in 
sonoporation, and making use of this knowledge to improve the technique, provides a 
rational approach to successfully develop sonoporation technique. 
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1.2.3 Dynamic behaviors of microbubbles driven by ultrasound 
Microbubbles play a key role in sonoporation. To enhance microbubbles stability, 
prolong their life-time, and potentially loading drugs and assisting targeted adhesion, 
microbubbles are formulated as lipid or polymer encapsulating microspheres with a 
water-insoluble gas core such as perfluorocarbon, with a radius of 1- 4 μm typically [26, 
69-72]. The shell of ultrasound contrast agents typical has a thickness of 10 to 100 nm 
[73]. When microbubbles oscillate driven by ultrasound field, lipid shell buckles into a 
bilayer during compression and shed during expansion [74-76]; while polymer and 
albumin shells usually rupture with discrete defects [77, 78]. The lipid shell, which is 
used on many shelled microbubbles, such as Definity® (Lantheus Medical Imaging, 
Billerca, MA) and Targestar™-SA (Targeson, La Jolla, CA), readily expands, ruptures, 
reseals, compresses and buckles under ultrasound field, which has been explicitly 
investigated theoretically and validated experimentally [79-86]. 
Accumulation of microbubbles on the specific molecular sites on the cell surface 
is a strategy used to increase site specificity and delivery efficacy. The ligand-receptor 
interactions exist extensively in biological media and exhibit high selectivity. Therefore, 
ligands have been applied to decorate the surface of microbubbles via biotin-avidin 
linkage. Consequently these ligands can guide microbubbles adhere on the cell surface, 
where the corresponding receptors are expressed. These modified microbubbles, capable 
of binding to a receptor, are called targeted microbubbles [72, 87-89]. In addition to 
surface decoration for targeted attachment, microbubbles can be manufactured to have 
more complicated structure to serve as drugs and genes carrier vehicles. Different 
strategies have been exploited, such as electrostatically coupled charged compound, DNA 
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or RNA, onto the cationic shell [90]; dissolving hydrophilic or lipophobic drugs in the 
oil, which incorporated into the lipid shell [91]; or attaching nanoparticles through biotin-
avidin bridging system [92]. 
No matter whether the drug molecules are co-administrated with microbubbles or 
loaded within the microbubbles, ultrasound pulses are applied to stimulate the 
microbubbles to facilitate sonoporation and the intracellular uptake of drug and genes. 
The outcome depends on the dynamic behaviors of microbubbles driven by ultrasound 
exposures. Based on direct optical observation, individual microbubble behaviors have 
been observed to exhibit phenomena including oscillation, fragmentation, micro fluidic 
jetting, translation, and coalescence [13, 84, 93-98]. Inertial cavitation is the expansion 
and contraction as well as collapse of bubbles driven by the inertia of the surrounding 
fluid and occurs when the acoustic pressure amplitude is above a threshold level [99]. In 
inertial cavitation, microbubbles first grow in volume, and then implode violently, 
resulting in fragmentation, microjetting, generation of highly reactive free radicals and 
even emitting photons (sonoluminescence) [94, 100-103]. In non-inertial cavitation or 
stable cavitation, microbubbles oscillate with relatively small amplitude at the frequency 
of incoming ultrasound. Microstreaming also occur as a result of cavitation [104-106]. In 
addition, microbubbles are subjected to a net force, the (primary) acoustic radiation force, 
which is associated with the applied ultrasound field [107-109]. If multiple microbubbles 
are present proximately, microbubbles are also subjected to the secondary acoustic 
radiation force, resulting from the scattered acoustic field generated by the other 
pulsating microbubbles [109-112]. The secondary radiation force can cause attraction or 
repulsion of microbubbles. Aggregation and coalescence (fuse into one big bubble) 
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among multiple microbubbles are mostly driven by secondary radiation force [83, 111-
113].  
1.2.4 Disruption of the cell membrane 
Ultrasound induced microbubble dynamic activities have been reported to be able 
to disrupt cell membrane. Prentice et al have demonstrated that fluid microjet was 
produced when encapsulated microbubbles excited by ultrasound in proximity to cell 
monolayer attached on a rigid substrate [13]. And the compression of cells due to the 
expansion of microbubbles was also suggested to be a possible way leading to membrane 
permeability change [97]. Evidence has been shown that shear stress built up with 
microstreaming generated by gentle/linear bubble oscillations is sufficient to rupture lipid 
membranes [114].  
It is indicated that nano- to micro scale pores generated on the cell membrane is 
the cause for increased membrane permeability and transporting of drug and gene is 
mainly via these pores. Great efforts have been made to visualize and characterize the 
pores. Scanning electron microcopy (SEM) revealed the presence of pores with the 
diameter from 100 nm to 1μm [14, 17, 56, 115-118]. Atomic force microscopy (AFM) 
images [13, 119], transmission electron microscopy (TEM) images [15] and confocal 
fluorescence microscopy image [15] confirmed the plasma membrane incontinuity in 
sonicated cell surface; although the dimension of the break varies greatly, from 1 nm to 
1μm diameter. Due to rapid resealing of the pores, however, these post ultrasound assays 
may not accurately obtain the pore information. Previous study in our lab employed 
voltage clamp technique using a Xenopus laevis oocyte model and estimated the pore size 
to be in the order of 100 nm [120].  
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1.2.5 Transmembrane transport by sonoporation and down-stream effects 
Despite many investigations, the detailed processes and mechanisms of drug and 
gene uptake and intracellular trafficking pathway via sonoporation is still under debate. 
The transmembrane transport appears to be dependent on the size of the agents to be 
delivered [15, 121, 122]. Small molecule, such as calcein, was homogeneously 
distributed throughout cytosol as well as in nuclei. Fewer uptakes were observed for 
larger molecules along with less homogeneous distribution and limited access to nuclei 
[15, 121]. The co-localization of macromolecules and endocytosis markers implied that 
endocytosis was also involved in transporting macromolecule such as plasmid  by 
sonoporation[121, 123], although contradictory evidences were published as well [40].  
In addition to pore formation or triggering endocytosis, other bioeffects have also 
been reported to be associated with sonoporation. Ca
2+
 influx was reported by several 
research groups [14, 16, 124-129], including the early studies in our lab that 
demonstrated Ca
2+
 influx and oscillation in Chinese hamster ovary (CHO) cells [128, 
129]. Juffermans et al suggested that the formation of hydrogen peroxide (H2O2) 
provokes Ca
2+
 influx [124]. Apoptosis has been reported in cells exposed to ultrasound 
application [130-134]. It was suggested that the reactive oxygen species (ROS) generated 
from mitochondria, rather than ROS directly produced by inertial cavitation of 
microbubbles in medium, combined with Ca
2+
 influx play a critical role in ultrasound 
induced apoptosis [133]. The results from both fluorescent imaging of voltage sensitive 
dye (di-4-ANEEPs) stained cell membrane [135], and whole-cell current clamp technique 
[136-138] illustrated that hyperpolarization occurred during ultrasound exposure in the 
presence of microbubbles; and activation of BKca channels were proposed to be the 
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cause for hyperpolarization. The reversible cytoskeletal F-actin fiber arraignment and 
number change were reported to be resulted from ultrasound exposure alone and more 
pronounced with the present of microbubble [126]. 
1.3 Rationale and significance of this study 
Sonoporation, as mentioned above, provides an advantageous opportunity to 
facilitate targeted intracellular uptake of drugs and genes. At present, the understanding 
of sonoporation mechanisms is insufficient. The difficulties in sonoporation mechanisms 
studies arise from the inherently transient, dynamic, microscopic, complicated bio-
chemical-physical nature involved in the interaction of ultrasound excited microbubbles 
with cells. In many sonoporation studies, freely floating microbubbles were employed [8, 
139-141]. This adds extra factor to the complexity and the uncertainty of the dynamic 
process. Therefore, creating a controlled environment of microbubble and cell interaction 
is important for investigation of sonoporation mechanisms.  
Many studies have been reported to optimize sonoporation delivery outcomes by 
manipulating ultrasound parameters as well parameters such as bubble concentration, 
concentration of agents to be delivered [142-145]. In the absence of mechanistic 
understanding, however, these studies are limited by their specific experimental 
configuration and condition.  
To explore the cellular/molecular biological consequences followed by cell 
membrane rupture in sonoporation, techniques, such AFM, SEM, TEM, and confocal 
fluorescent microscopy were used [13, 15, 115, 119, 121]. The superior spatial resolution 
of these imaging techniques provides spatial details of a fixed cell after ultrasound 
treatment. However, since there is relatively huge time span between plasma membrane 
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poration in live cells and examination of fixed cell sample, these findings may not be 
directly correlated with the actual sonoporation process.  
In this study, we created well-controlled in vitro experimental environments by 
physical restriction of microbubbles and attaching microbubbles onto cell surface via 
ligand-receptor reaction to study the transient process of sonoporation at cellular level. 
We explicitly elucidate the relationship between membrane rupture and [Ca
2+
]i transient 
and intracellular Ca
2+
 wave; extensively explored the dynamic microbubble activities in a 
population under various ultrasound exposures and spatial-temporally correlated with 
delivery outcomes; and achieved enhanced gene transfection efficiency by optimizing 
microbubble dynamics instead of blind adjustment of ultrasound parameters.     
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Chapter 2  
 
Intracellular Delivery and Calcium Transients Generated in Sonoporation 
Facilitated by Microbubbles 
 
In this chapter, we described in detail our study to investigate the change of cell 
membrane permeability and changes of intracellular calcium concentration ([Ca
2+
]i) 
generated by ultrasound-driven microbubbles. Using a combination of imaging 
techniques, real-time fluorescent microscopy, we obtained results of intracellular uptake 
and calcium transients that were spatiotemporally correlated with high-speed bright field 
images of ultrasound-driven microbubbles activities.   
2.1 Introduction 
Ultrasound application with microbubbles have demonstrated the promise to 
facilitate intracellular transport of different kinds of therapeutic agents, such as drug 
molecule, genetic materials, that are otherwise impermeable to the cell [11, 146-152]. 
One major route for intracellular uptake is suggested to be through transient and 
reversible pores created on the cell membrane [12-14]. However, a detailed mechanistic 
description of sonoporation and its full range of bioeffects remain to be elucidated [153].  
Calcium ion as is a ubiquitous intracellular signal responsible for regulating 
numerous cellular activities, such as control of muscle contraction, neurotransmitter 
releases, synaptic plasticity, cell proliferation and apoptosis. Because of the importance 
of calcium as a second messenger, the impact of sonoporation on intracellular and 
intercellular calcium signaling becomes one of the most important bioeffects aspects that 
15 
 
researchers in therapeutic ultrasound area investigated. Recent studies have demonstrated 
that cells treated with ultrasound and microbubbles can exhibit temporal calcium 
transients [124, 154, 155]. In particular, we have shown temporal calcium oscillations 
and spatial waves can be generated, resulting in calcium changes in cells away from the 
cells that directly interact with microbubbles over distances of hundreds of microns and 
tens of seconds after ultrasound application [156]. Due to the central role that calcium 
ions play in cellular functions regulation and intercellular communication, changes in the 
intracellular calcium ion concentration [Ca
2+
]i resulting from ultrasound exposure may 
have unintended consequences in ultrasound-mediated delivery applications such as 
cardiac gene transfection and targeted cancer drug delivery. However, while these studies 
suggested that calcium response occurs as a result of ultrasound application in the 
presence of microbubbles, it is not explicitly clear whether sonoporation of the cell 
membrane with intracellular delivery directly causes [Ca
2+
]i activities.   
In this study, we employ a combination of imaging techniques to determine 
whether sonoporation of cardiomyoblast cells and [Ca
2+
]i changes are generated by the 
interaction between individual microbubbles and cells via pore formation. Ultrasound-
driven microbubble activity was imaged using high-speed bright-field imaging, which 
was synchronized and spatially correlated with a real-time fluorescence imaging system 
specially designed to simultaneously measure changes in [Ca
2+
]i and membrane 
permeabilization using multiple fluorescent dyes.  
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2.2 Materials and methods 
2.2.1 Cell culture 
H9c2 rat cardiomyoblast cells (ATCC, Manassas, VA) were grown in a 
humidified incubator at 37°C and 5% CO2 in cell culture flasks containing the complete 
cell culture medium consisting of Dulbecco’s modified Eagle’s medium (Gibco 
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (HyClone, Logan, 
UT) and 1% penicillin-streptomycin (HyClone, Logan, UT). Two days before the 
sonoporation experiment, the cells were harvested from the flasks and seeded into an 
OptiCell™ chamber (Nunc, Rochester, NY) filled with the same cell culture medium. 
OptiCell™ chambers consist of two parallel, gas-permeable, cell-culture-treated, 
polystyrene membranes (50 cm
2
, 75 μm thick, 2 mm apart) attached to a standard 
microtiter plate-sized frame, shown in Fig.2-1B. At the time of experiment, the cells had 
reached approximately 90% confluency. 
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Figure 2-1 (A) Schematic diagram of experimental apparatus for spatiotemporal measurements 
of intracellular delivery of fluorescent marker and calcium transients generated by ultrasound-
driven microbubble activities (B) Picture of OptiCell™ cell culture chamber (C) Schematic 
diagram of OptiCell™, cells and Definity® microbubbles. 
 
2.2.2 Microbubbles 
Definity
®
 (Lantheus Medical Imaging, Billerca, MA) consists of distributed 
encapsulated microbubbles, each with a C3F8 gas core encapsulated by an outer 
phospholipid shell. Immediately after activation following the manufacturer’s protocol, 
B 
A 
C 
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the suspension contains approximately 1.2×10
10
 microbubbles/mL with mean diameter 
range of 1.1 m–3.3 m. However, for the current experiments, the solution was diluted 
with PBS to have a final concentration of 10
6
 microbubbles/mL such that most cells had 
only 1 or 2 bubbles in their immediate vicinity. During the experiment, OptiCell™ was 
facing down, so that microbubbles can be in close contact with cells, as illustrated in 
Fig.2-1C.  
2.2.3 Measurement of intracellular calcium concentration 
Fluorescence imaging of intracellular calcium concentration, [Ca
2+
]i, was 
performed using the indicator dye fura-2 [157]. To load the dye into the cells, the cells 
were incubated for 60 minutes at 37°C and 5% CO2 in complete cell culture medium 
containing 7.8 M fura-2AM (Invitrogen, Carlsbad, CA) dissolved in DMSO and 0.05% 
v/v of 10% w/v Pluronic F-127 (Invitrogen, Carlsbad, CA) in water. After incubation, 
excess dye was removed by washing the cells three times with complete culture medium 
before ultrasound exposure. The OptiCell™ chamber was then filled with Dulbecco’s 
Phosphate-Buffered Saline solution (DPBS, Gibco Invitrogen 14040, Carlsbad, CA), 
which has [Ca
2+
]o = 0.9 mM. Quantitative measurement of [Ca
2+
]i was achieved via 
calibrated ratiometric imaging. The “raw” emitted fluorescence intensities (at 510 nm) for 
both excitation wavelengths 340 nm and 380 nm in each cell was determined from 
manually segmented regions of the cell in the images. The background-corrected 
fluorescence intensities (F340, F380) were obtained by subtracting the fluorescence 
intensity from an area free of cells from the raw intensities. The ratio R=F340/F380 was 
related to the change in the intracellular calcium concentration according to 
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                                      Equ. 2-1 
where the parameters           ,           ,    
          and     
           
were obtained by using a fura-2 calibration kit (Invitrogen F6774, Carlsbad, CA). The 
calibration kit contains samples of 0 μM, 0.017 μM, 0.038 μM, 0.065 μM, 0.100 μM, 
0.150 μM, 0.225 μM, 0.351 μM, 0.602 μM, 1.35 μM and 39 μM free calcium standard 
solution with 50 μM fura-2 in each sample. It provided another sample without fura2, 
which was used as the background measure. The measurements at different calcium 
concentration were all corrected by the background intensity. The results for 
    and     
    were obtained using 0 μM calcium sample, while the results for      
and     
   were obtained using 39 μM calcium sample. All the calibration measurement 
were carried out using 40x extra long working distance objective, at the same setting as in 
experiments, with exposure time 656 ms, and 100% electron multiplication gain in Easy 
Ratio Pro software (PTI, Birmingham, NJ). A set of fluorescent curves of 340 nm and 
380 nm excitation were generated using the 11 different calcium concentration solution 
samples, a figure with    {
      
      
      
        
    } as y-axis and               as x-
axis was plotted. A linear fitting was employed, the x-intercept should be equal to the log 
of the apparent   , as shown in Fig.2-2. The measurement was without cells and used 
glass cover slides, which was different from the intracellular environment and OptiCell™ 
configuration in real experiment, so to convert the ratio of 340 nm and 380 nm into 
[Ca
2+
]i, dissociation coefficient Kd = 155 nM was taken from the literature [158].  
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Figure 2-2 Experiment results using the fura2 calcium concentration calibration kit. A linear 
fitting was applied. 
 
Fura-2 is a ratiometric fluorescent dye which binds to free intracellular calcium 
and the spectrum varies with different calcium concentration. However, there is one 
excitation wavelength, at which the emission of fura-2 is independent from calcium 
concentration but fura-2 dye concentration, which is named as isosbestic point (Fig.2-3A) 
The isosbestic point is reported around 360 nm. We conducted experiments to confirm 
that the isosbestic point of fura-2 in our experiments to be 360 nm by examining the 
emission intensities as a function of time in cells sequentially excited at 340 nm, 360 nm, 
361 nm to 365 nm, 380 nm, and 539 nm (for PI excitation) while ultrasound application 
initiated change (increase) in [Ca
2+
]i. In the cells that did not exhibit PI uptake but with 
(delayed) change in [Ca
2+
]i (e.g., as a result of a calcium wave but not pores on the 
membrane), the emission intensity from 360 nm excitation stayed unchanged, while the 
emission intensities from excitation at longer wavelengths increasingly resembled the 
response from excitation at 380 nm (which decreases in amplitude when [Ca
2+
]i 
increases), as shown in Fig.2-3B. 
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Figure 2-3 (A) Spectra of fura2. Isosbestic point is the excitation wavelength, at which fura2 
fluorescence intensity is independent from calcium concentration, cited from Invitrogen 
handbook. (B) Experimental detection of isosbestic point. A cell, which had no PI uptake, 
indicating no pore created, but [Ca
2+
]i change, was excited at wavelength of 360 nm to 365 nm 
and 380 nm. 360 nm was found as isosbestic point, as no change was observed of emission when 
the cell was excited at 360 nm, while the cell experienced [Ca
2+
]i change. 
 
2.2.4 Determination of membrane permeabilization with propidium iodide 
Change in cell membrane permeabilization by ultrasound was assessed by 
detecting the intracellular fluorescence intensity of the intercalating agent propidium 
iodide (PI; 668 Da) (Sigma Aldrich, St. Louis, MO). After loading with fura-2, PI was 
added to the extracellular solution to achieve a final concentration of 120 μM. To detect 
PI, the specimen was excited at 539 nm, and emission was detected at 610 nm. 
(Excitation at the ultraviolet wavelengths caused a very low-intensity emission from PI 
that cannot be fully distinguished from the emission from the fura-2; however, this effect 
is estimated to cause an error of less than 5%.) As PI only fluoresces at these wavelengths 
when inside the cell, it provides a good real-time marker for delivery via membrane 
disruption from the extracellular solution with real-time fluorescence imaging. While 
irreversible changes in PI fluorescence are often used as a marker for cell death, here 
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transient changes in PI fluorescence were also used as a marker for permeation of the cell 
membrane.  
2.2.5 Optical imaging and data analysis 
A schematic diagram of the experimental apparatus is shown in Fig.2-1A. The 
fura-2-loaded cells in the OptiCell™ chamber filled with the solution of PI and 
microbubbles were placed on a 37°C heating stage of an inverted microscope (Nikon 
Eclipse Ti-U, Melville, NY). The real-time fluorescence imaging employed a 
monochromator (DeltaRAM X™, PTI, Birmingham, NJ) with 5 nm bandpass to 
repeatedly filter light from a 75 W xenon lamp at the various excitation wavelengths 
previously described, with an exposure time of 656 ms during fura-2 imaging and 400 ms 
during PI imaging. The excitation light was directed through either a 20 Super Fluor 
(Nikon MRF00200, Melville, NY; NA 0.75) or a 40 Plan Fluor objective (Nikon 
MRH08420, Melville, NY; NA 0.60) and the light subsequently emitted from the cells 
was passed through a polychroic filter (Chroma 73000v2, Rockingham, VT) with 
passbands in the green and red. The resulting series of 16 bit grayscale photomicrographs 
were acquired with a cooled CCD camera (Photometrics QuantEM, Tucson, AZ) at a 
512  512 resolution. Electron multiplication gain in the camera was set to 100% during 
fura-2 imaging and 80% during PI imaging. The image acquisition and analysis from this 
camera were performed using the software package Easy Ratio Pro (PTI, Birmingham, 
NJ). To create the calibrated calcium images, image post-processing was performed using 
MATLAB (Mathworks, Natick, MA) and MetaFluor Analyst (Molecular Devices, 
Downingtown, PA). Noise in the regions outside the cells was suppressed by using 
intensity-modulated display approach [159] using the 340 nm images for modulation, as 
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described previously [154]. The grayscale PI images were artificially-colored red for 
display purposes by zeroing the green and blue components of each pixel. 
Microbubble activity was captured using a high-speed, bright field camera 
(Photron FASTCAM SA1, San Diego, CA) at a resolution of 1024  1024, rate of 5400 
frames/s, and total exposure time of ~2 s. The specimen was illuminated with metal-
halide light source (Dolan-Jenner MH-100, Boxborough, MA) only during the high-speed 
imaging.  
2.2.6 Ultrasound application and calibration 
The ultrasound system used for the experiment consisted of a non-focused 
circular transducer specially-designed and constructed for our study (1 MHz center 
frequency, 0.635 cm diameter, Advanced Devices, Wakefield, MA). The transducer was 
driven by a function/waveform generator (Agilent Technologies 33250A, Palo Alto, CA) 
and a 75 W power amplifier (Amplifier Research 75A250, Souderton, PA). The 
transducer was characterized in free field using computer-controlled system with a 40 μm 
calibrated needle hydrophone (Precision Acoustics HPM04/1, UK). Prior to the 
experiment, the transducer was aligned with the field of view (FOV) of the microscope 
objective using a thin wire attached on the top surface of a water-filled OptiCell™ with a 
plastic wall attached around its entire edge to create a small tank, which was 
subsequently filled with deionized water for acoustic energy coupling.  
This alignment apparatus was then removed and replaced by the OptiCell™ 
containing the cells loaded with fura-2 and with PI in the extracellular medium, also with 
a coupling tank on top filled with deionized water. The water in the tank is physically 
isolated from the cells by the upper membrane of the OptiCell™ chamber. The transducer 
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was positioned such that the active surface of the ultrasound transducer submerged in 
solution was ~7 mm from the cells at the bottom of the dish at an angle of approximately 
45 degrees (Fig.2-1). The transducer had a near field distance of ~6.4 mm and spatial 
width (half-max) at 7.5 mm, which is the approximate distance between the transducer 
and OptiCell
TM
 chamber during the experiments. As such, the entire FOV of the 
microscope (200  200 µm at 40 objective, 400  400 µm at 20 objective) was 
insonified. The cells are attached to the top polystyrene membrane of the OptiCell™ 
chamber. Standing wave effects [140] due to the bottom membrane of the OptiCell™ 
were minimized by angling the ultrasound beam and using short pulses. The generated 
ultrasound waveforms at the region of interest had peak negative pressure of 0.27 MPa as 
determined from the calibration above. A single ultrasound tone burst of 10 or 15 cycles 
was applied during each experiment. 
2.2.7 Experimental protocols 
Two protocols were used in our experiments, schematically illustrated in Fig.2-4. 
In the first protocol, the microbubbles were imaged during ultrasound application and 
included the following steps (1) baseline fluorescence imaging performed with sequential 
excitation at 340 nm, 380 nm and 539 nm for 20 s; (2) baseline bright field high-speed 
imaging performed for 10 ms; (3) ultrasound application during the high-speed imaging; 
(4) fluorescence imaging continued with the same excitation sequence for up to 5 min. 
Synchronization of ultrasound pulse and bright field imaging ensured that bright field 
images would be acquired before, during, and after the ultrasound pulse. Immediately 
after the bright field imaging was completed, the microscope was manually switched 
back to the fluorescence camera, which continued to run throughout the bright field 
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imaging to maintain a continuous time base during the entire duration of the experiment. 
Since light could only be directed to one camera at a time, the information from the 
fluorescent dyes is not captured during the time when the ultrasound pulse is applied and 
the bright field imaging is performed.  
The second protocol involved only fluorescence imaging without the bright field 
imaging. In addition to excitations at 340 nm, 380 nm and 539 nm, fluorescence imaging 
in the second protocol also included excitation at 360 nm, the isosbestic wavelength of 
fura-2, to investigate the leakage of the pre-loaded fura-2 out of the cell due to 
sonoporation of the cell membrane. At the isosbestic point of the dye, the fluorescent 
emission is independent of the [Ca
2+
]i. As such, this wavelength was used as a measure of 
fura-2 dye concentration [160-162]. 
 
Figure 2-4 Schematic diagram of experimental protocols for monitoring intracellular delivery 
and calcium transients generated by ultrasound-driven microbubbles. 
 
2.2.8 Curve fitting 
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Following a previous proposed model [163, 164], the change in PI intensity due to 
PI uptake was fitted to a two-parameter exponential recovery function 
        ∞                                              Equ. 2-2 
where t = 0 is the time of the ultrasound application, PI is the characteristic PI 
recovery time and PI is the asymptotic PI intensity at long times. Analogously, intensity 
changes due to fura-2 dye loss measured with the 360 nm excitation were fitted to a two-
parameter exponential decay function 
               
       
      
                                     Equ. 2-3 
where 360F is the characteristic decay time for fura-2 dye leakage and
0
360F and

360F are the initial fura-2 intensity from 360 nm excitation before ultrasound exposure 
(known) and the asymptotic fura-2 intensity at long times. Fitting was performed using 
the routines of the MATLAB Curve Fitting Tool using the default parameter on all data 
except those with signal-to-noise ratios so low that meaningful fitting was not possible. 
Goodness-of-fit was assessed using the R
2
 parameter (ratio of the sum of squares of the 
regression and the total sum of squares). 
At each experimental condition, multiple experiments were conducted. The 
number of experiments are indicated where the results are reported. 
2.3 Results 
2.3.1 Ultrasound-driven microbubble activities, sonoporation, and calcium 
transients 
In the set of experiments using the first protocol, microbubble dynamics were 
observed using the high-speed camera during the application of ultrasound while the 
intracellular delivery of the marker PI from the extracellular solution and the [Ca
2+
]i 
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response were measured using real-time fluorescence imaging. Control experiments with 
no microbubbles or no ultrasound yielded no PI uptake. Only those microbubbles that 
were immediately adjacent to the cell resulted in any observable changes in the cells. 
Figure 2-5 shows the results of a typical experiment. Figures 2-5A and 2-5B show pre-
ultrasound PI and [Ca
2+
]i (pseudocolor) images superimposed on the bright field image of 
the same FOV taken prior to the start of the fluorescence imaging and ultrasound 
application with the region of interest indicated by the solid while lines on the main body 
of two cells. Cell 2 is adjacent to a microbubble (indicated by the arrow) while Cell 1 is 
not. The absence of PI in cells (no red in Fig.2-5A) indicates their viability with intact 
membrane (the extracellular solution contains PI). After initial baseline fluorescence 
imaging, the microscope is switched to the high-speed brightfield imaging followed by 
ultrasound application. Figures 2-5C and 2-5D show the mean PI fluorescence intensity 
and [Ca
2+
]i, respectively, as a function of time for the regions of interest corresponding to 
Cells 1 and 2 in Fig.2-5A and 2-5B. The significant increase of PI intensity in Cell 2 is 
clearly shown in Fig.2-5C, indicating intracellular PI delivery via sonoporation. Figure 2-
5D shows that the average [Ca
2+
]i also increases significantly in Cell 2 before eventually 
returning to an equilibrium value. The return of the [Ca
2+
]i of Cell 2 to an equilibrium 
value suggests that the cell is still alive even though delivery has occurred. Figure 2-5E 
shows the ultrasound-induced stimulation of the microbubble adjacent to Cell 2. The 
bubble is seen to fragment into three smaller bubbles resulting from the ultrasound pulse. 
In contrast, both PI fluorescence intensity and the [Ca
2+
]i are essentially unaffected for 
the nearby Cell 1 in the absence of bubble activities in close proximity. 
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Figure 2-5 Propidium iodide (PI) delivery and intracellular [Ca
2+
]i transients are temporally 
correlated with ultrasound-driven microbubbles. (A) Bright field image with superimposed PI 
fluorescence image before ultrasound application. No PI is observed in the cells. The solid lines 
show two regions of interest within cells (Cell 1 and Cell 2). The arrow points the microbubble 
next to Cell 2. (B) Bright field image with superimposed pseudocolor [Ca
2+
]i image, indicating 
the initial [Ca
2+
]i distribution before ultrasound application. (C) PI fluorescence intensity changes 
(from the baseline) as a function of time for Cells 1 and 2 induced by ultrasound simulation of the 
microbubbles. (D) [Ca
2+
]i changes for Cells 1 and 2 as a function of time. In C and D, the break 
indicates the period when light was directed to the high speed camera. (E) High-speed camera 
recordings of the ultrasound-driven microbubble inside the dashed frames in (A) and (B) show 
bubble fragmentation.  
 
2.3.2 Spatiotemporal evolution of intracellular marker and calcium 
Figure 2-6 shows spatiotemporal evolution of the intracellular PI (Fig.2-6A) and 
[Ca
2+
]i changes (Fig.2-6B), corresponding to the traces of Figs.2-5C and 2-5D. The white 
lines show the of the regions of interest corresponding to Cell 1 and Cell 2 while the 
location of the microbubble before ultrasound is indicated by the small circle. Figure 2-
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6A shows that the PI delivery originates in the immediate vicinity of the microbubble at 
the time of the ultrasound application and then diffuses to the other areas of Cell 2 over 
the next 4 minutes, while Cell 1 is entirely unaffected. Figure 2-6B shows that the [Ca
2+
]i 
increases from less than 100 nM to more than 500 nM and then recovers. Again, the 
[Ca
2+
]i of Cell 1 is unaffected. Taken together, Figure 2-5 and 2-6 illustrate that PI 
delivery and change in [Ca
2+
]i are spatially and temporally correlated in cell sonoporation 
due to an ultrasound-stimulated microbubble. 
[Ca
2+
]i transients and PI fluorescence changes induced by ultrasound-stimulated 
microbubbles like those seen in Figs.2-5 and 2-6 were observed in 18 independent 
ultrasound experiments (exposures) with 28 different cells each with one adjacent 
microbubble. In every case of PI delivery, [Ca
2+
]i changes also occurred simultaneously. 
While the individual bubble oscillations were not resolved, the high-speed bright field 
imaging clearly showed a change in the bubble after each ultrasound pulse.  
This simultaneous occurrence of microbubble changes, PI uptake, and [Ca
2+
]i 
transients indicates transient pore formation induced by the microbubble stimulation is 
likely the cause for the observed [Ca
2+
]i transients. 
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Figure 2-6 Intracellular delivery of propidium iodide (PI) and intracellular [Ca
2+
]i transients are 
spatially correlated with stimulation of microbubbles by ultrasound. (A) Time-lapse PI 
fluorescence images and (B) pseudocolor [Ca
2+
]i images, corresponding to the traces shown in 
Fig.2-5C and D respectively. The solid lines show the two regions of interest (Cell 1 and Cell 2), 
while the circle outlines microbubble next to Cell 2 at the beginning of the experiment. The color 
bar indicates the [Ca
2+
]i in μM. The first row shows the cells before ultrasound exposure while the 
subsequent rows show the cells at the indicated times after ultrasound application. 
 
2.3.3 Delayed calcium transport in cells without pore formation  
While the results described above demonstrated that immediate [Ca
2+
]i transients 
are correlated with PI delivery in cells affected by ultrasound-driven microbubble 
activities, cells with delayed [Ca
2+
]i transients showed no PI uptake. Figure 2-7 shows the 
spatiotemporal evolution of the PI delivery (Fig.2-7A) and the changes in [Ca
2+
]i (Fig.2-
7B) for five cells and corresponding time traces (Fig.2-7C and D). Prior to the application 
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of ultrasound, no cells exhibited PI fluorescence and all the cells showed normal levels 
[Ca
2+
]i. However, immediately after the ultrasound is applied, only Cell 1 exhibited a 
calcium transient with PI delivery (in red) indicating sonoporation on the right side of the 
cell. Subsequently, the nearby Cells 2–5 showed an increase in [Ca2+]i with delays of 6 s, 
6 s, 12 s, and 42 s, respectively, but exhibited no sign of PI delivery. After 140 s, all cells 
had returned to their equilibrium [Ca
2+
]i except Cell 1. It is noted that the amplitude of 
the increase in [Ca
2+
]i in sonoporated cells is much higher than those in cells with delayed 
change in [Ca
2+
]i due to calcium waves. 
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Figure 2-7 (A) Time-lapse sequence of PI fluorescence images and (B) time-lapse sequence of 
pseudocolor [Ca
2+
]i images for five cells, where the color bar in row B indicates the [Ca
2+
]i in μM. 
Only Cell 1 (arrow) shows immediate [Ca
2+
]i change at the time of ultrasound and immediately PI 
uptake are seen in only cell 1 (arrow pointed). Cells 2 to 5 show delayed [Ca
2+
]i transients without 
any PI uptake. (C) [Ca
2+
]i as a function of time for Cells 1–5, showing the immediate change in 
calcium (cell 2) and delayed calcium change (cells 2–5). The [Ca2+]i returned to a higher level 
than initial [Ca
2+
]i for Cell 1, while all the delayed cells returned to approximately their initial 
level. (D) PI intensity change as a function of time for Cells 1–5. Only Cell 1 shows any PI 
uptake. 
 
 
2.3.4 Concentration-gradient driven, bidirectional transport of markers and pore 
closure 
With clear evidence for the correlation between marker delivery, calcium 
changes, and microbubble activity, a second set of experiments was performed to focus 
on sonoporation quantification. A series of 15 independent experiments were performed 
using the same approach as in the previous section using the second protocol with the 
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additional excitation at the 360 nm as an independent measure of the fura-2 dye 
concentration. For a total of 36 different cells, in all but one of the cells, simultaneous PI 
uptake and [Ca
2+
]i transients were observed immediately after ultrasound exposure. In 
one case, no PI uptake was detected but a small immediate [Ca
2+
]i transient still occurred. 
It is possible that PI uptake may have still occurred but may have been below the 
detection threshold of our system ([Ca
2+
]i > 20.4 nM and under PI intensities > 20.4 
units). 
First, the effect of sonoporation on the post-ultrasound equilibrium values of the 
delivery marker and [Ca
2+
i] was considered, where five minutes was empirically 
determined to be a sufficient time period for most cells to reach equilibrium or near-
equilibrium conditions. Figure 2-8 shows scatter plots of [Ca
2+
]i change (max [Ca
2+
]i 
increase or [Ca
2+
]i increase at 5min= [Ca
2+
]i(t = 5 min) − [Ca
2+
]i(t = 0 min)) and PI 
intensity changes = PI(t = 5 min) − PI(t = 0 min). Only [Ca2+]i increase at 5min and PI 
intensity increase at 5 mins are positively correlated (linear correlation coefficient 
R = +0.91), showing both that sonoporation caused marker delivery and that increased 
delivery resulted in increased level of [Ca
2+
]i long (5min) after the ultrasound exposure 
had ended.  
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Figure 2-8 Scatter plot of [Ca
2+
]i change and PI intensity change, both at 5 min since the start of 
fluorescence imaging for 36 cells, showing positive correlation (R = +0.91).  
 
Next, the effect of sonoporation on the pre-loaded dye fura-2 was investigated. If 
sonoporation creates non-specific pores, then the preloaded dye might leak out of the cell 
as the delivery marker PI is transported into the cell.  
Figure 2-9A shows the typical result from sonoporated cells with the isosbestic 
point excitation included. The PI intensity increases in the cell after ultrasound 
application, indicating marker delivery due to pore formation. At the same time, the 
[Ca
2+
]i transiently increases and then decreases to an equilibrium level. Finally, the 
emission from 360 nm excitation decreased, implying a loss of fura-2 dye from the cell 
and thereby also indicating the existence of pore on the cell membrane. (Recall that the 
ratio of the emission intensities due to excitations at 340 nm and 380 nm is used to derive 
[Ca
2+
]i and is thus essentially independent of dye concentration.)  
The dashed lines on the figure (Fig.2-10A) show the fit of the PI uptake to Eq.2.2 
(   = 34.2 s,     = 58.4) and fura-2 dye loss to Eq.2.3 (     = 13.8 s,     
 = 166). Figure 
2-9B shows that the change in the emission intensity from the 360 nm excitation 
F360 change = F360 (t = 5 min) − F360 (t = 0 min) is negatively correlated with the PI 
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intensity change = PI (t = 5 min) – PI (t = 0 min) in these experiments (R = −0.78), 
indicating that amount of marker delivery is related to the amount of dye loss. Using the 
fitting Eq.2.2 and Eq.2.3, the mean and standard deviation of the exponential recovery 
time constant     for PI was found to be 50 ± 32 s, while the mean and standard deviation 
of the exponential decay time constant       for the fura-2 dye loss was 25 ± 15 s. 
Although the exponential time constants depend on a combination of factors, the 
asymptotic behavior of fluorescence intensities of PI and fura-2 (excited at 360 nm) 
suggests that the time constants reflect the resealing rate of the pores on the cell 
membrane.  
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Figure 2-9 Pore generation is corroborated by simultaneous PI uptake, [Ca
2+
]i increase, and fura-
2 dye loss. (A) Changes in PI fluorescence intensity, [Ca
2+
]i, and fura-2 fluorescence intensity 
from excitation at 360 nm as a function of time, as induced by ultrasound-driven microbubbles 
for the cell shown in the inset (arrow pointing to microbubble), indicating increase in [Ca
2+
]i, PI 
uptake, and fura-2 dye loss generated by ultrasound application. Dashed lines show fitting of PI 
uptake and fura-2 loss to exponential recovery or decay models. (B) The change of fura-2 
intensity from excitation at 360 nm and change of PI intensity change, both at 5 min since the 
start of fluorescence imaging for 36 cells are negatively correlated (R = −0.78), indicating loss of 
fura-2.  
 
2.3.5 Cell viability 
All of the cells affected by ultrasound-bubble included in this study (no data were 
excluded) and presented above were viable at the end of the 5 minute observation period 
after ultrasound application because they met the following conditions: (1) its ultrasound-
induced [Ca
2+
]i rises and then returns to an equilibrium value (although it may not 
necessarily be its initial value), (2) the PI intensity reaches a stable plateau which is much 
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lower than the PI intensity exhibited by the cells that were dead (verified by Trypan blue 
assay) before ultrasound application, shown in Fig.2-10, and (3) the fura-2 emission 
intensity due to 360 nm excitation (when bright-field imaging was not performed) drops 
but reaches a non-zero equilibrium value that is higher than the final equilibrium 
fluorescence intensity exhibited by the cells that were dead before ultrasound application 
(confirmed by Trypan blue assay). 
 
Figure 2-10  PI intensity difference in sonoporated but surviving cells (N=35), and dead cells 
(N=15), which were confirmed by Trypan blue staining. 
 
2.4 Discussion 
Previous studies without microbubbles [133] and with microbubbles [124, 156] 
have shown that cells increase [Ca
2+
]i when [Ca
2+
]out > [Ca
2+
]i but show no change or 
decrease in [Ca
2+
]i when [Ca
2+
]i > [Ca
2+
]out = 0. Both of these responses are consistent 
with Ca
2+
 transport into the cell through nonspecific pores, but existence of physical 
pores of membrane disruption, e.g., indicated by concomitant delivery of a membrane-
impermeable marker from the extracellular solution, was not explicitly demonstrated. In 
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the current study, the spatiotemporal correlation between the microbubble and change in 
PI fluorescence and [Ca
2+
]i (Fig.2-5 and Fig.2-6) in sonoporated cells indicate that the 
ultrasound-driven microbubble is the cause for the [Ca
2+
]i transients in these cells. 
However, it is possible that other intracellular mechanisms can also be triggered 
subsequently by the pore formation (e.g., calcium-induced calcium release controlled by 
the InsP3R and RYR families), as has also been suggested by others [135]. In general, the 
recovery of [Ca
2+
]i is mostly likely the result of several complex processes. The Ca
2+
-
ATPase pumps and Na
+
/Ca
2+
 exchangers on cell membranes extrudes Ca
2+
 to the outside 
whereas the sarco-endoplasmic reticulum ATPase pumps and mitochondria accumulate 
Ca
2+
 into the internal stores [165, 166]. 
           No distinguishable difference of [Ca
2+
]i transients and PI intensity change 
exhibited between two bubble reaction groups: shrink and fragment, nor clear trend were 
shown [Ca
2+
]i transients and PI intensity change as a function of bubble diameter 
reduction in the case of shrink. This may be explained as sonoporation is complicated 
system, although ultrasound excited bubble reaction plays the key role in the whole 
process, it’s the only determining factor for the outcomes. The natural variations of 
endoplasmic reticulum, sarcoplasmic reticulum and mitochondria quantity and 
distribution in individual cells may lead to various [Ca
2+
]i transients responses, while the 
variations of intracellular RNA or DNA may result into different PI intensity changes. In 
addition to the aspect of variation in cells, the bubble location on cell membrane, and the 
distance of bubbles to cell surface was not under precious control in current setting, 
where the contact of microbubble and cell surface was generated by buoyancy of 
microbubbles and confinement of the OptiCell™ upper membrane. If more sophisticated 
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strategy can be used better control the relative position of microbubbles and cell 
membrane, we could improve the controllability of sonoporation outcomes. 
Cells with delayed [Ca
2+
]i transients with respect to the cells with immediate 
[Ca
2+
]i transients generated by ultrasound-driven microbubble as well as PI uptake 
showed no PI delivery (Fig.2-7), indicating that the delayed transients are not directly due 
to pores on the membrane, but result from “calcium waves”, as observed previously in a 
different cell type [154, 156]. Hence [Ca
2+
]i transients alone are not a good indicator for 
permeabilization in sonoporation for intracellular macromolecule delivery. Tsukamoto et 
al. [155] similarly have observed the existence of calcium transients delayed with the 
respect to the time of ultrasound application, particularly in cells adjacent to cells that 
exhibited membrane rupture (as determined by an irreversible decrease in the 380 nm 
excitation signal of fura-2). In studies on a variety of cells, [Ca
2+
]i transients have been 
shown to result from both intracellular [167] and extracellular transport of messengers 
[168].  
A recent study showed that delivery by endocytosis can also occur as a result of 
ultrasound exposure, particularly for larger weight molecules (> 150k Da) [121]. Imaging 
from the current study showed that the intracellular PI delivery was only seen initially at 
the area adjacent to the ultrasound-driven microbubble, despite the fact that the entire 
FOV is exposed to ultrasound. The PI fluorescence gradually became increasingly 
distributed inside the cell, and calcium changes also rapidly occur throughout the cell. 
These observations are inconsistent with the localization within vesicles that is observed 
in endocytotic delivery. Instead, it is more likely that ultrasound mediated intracellular 
delivery of PI observed in our experiments results from the passive transport of 
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macromolecules into the cytosol through non-specific pores and/or physical disruption of 
the membrane [13, 15, 97, 115, 169-172].  
The mean 99% recovery times observed in our study from time-dependent 
measurements of marker intensities (5 PI ≈ 250 s or 5 360F ≈ 125 s) are somewhat slower 
than those observed previously in mechanical wounding of 10 to 30 s [160-162] of 
murine fibroblasts, but faster than the recovery times of 600 s in some electroporation 
experiments based on averaging over many murine myeloma cells [163, 164]. These 
differences can come from a number of factors, including difference cell types, methods 
of membrane wounding, as well as fluorescent dye kinetics. In addition, the scatter plots 
of Fig.2-8 and Fig.2-9 suggest that there is a significant amount of variability in the 
sonoporation process in terms of the amount of marker delivery or loss. It is possible that 
inherent differences in nucleic acid distribution or concentration within the cell, 
intercellular variations in fura-2 dye loading, and differences in the size and distance of 
the microbubbles could contribute this variability, but effects from these individual 
factors were not determined. 
Sonoporation has the ability to enhance the delivery of large-molecular weight 
drugs, genes, and proteins to cells, but pore formation in the cell membrane may also 
result in other cellular events such as calcium transients or waves as well as 
hyperpolarization induced by calcium or stretch activation of ion channels [135, 136, 
138, 173]. It has been suggested that arrhythmogenic changes that have been clinically 
observed during echocardiography [174, 175] may result from calcium transients [124, 
135]. Cardiac contractions can follow calcium-induced calcium release [176-178], and 
calcium transients and waves can be involved in arrhythmias [179-181]. Calcium waves 
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have been found in migrating tumor cells, and an anti metastatic drug has been shown to 
affect the calcium-wave properties of an invasive cancer cell line [68]. Another recent 
study has shown that even low-intensity ultrasound can induce excitation in neurons via 
activation of sodium-gated and calcium-gated ion channels [69], which may then also 
have implications for efforts to use ultrasound as a means to transiently permeate the 
blood-brain barrier. Although the exact consequences require further investigation, these 
cellular events could have important implications in many applications such as ultrasound 
mediated cardiac gene delivery and targeted cancer drug delivery and are thus worthy of 
further careful studies in order to develop sonoporation as a safe and robust strategy for 
drug and gene delivery.  
2.5 Conclusion 
Results from this study demonstrate that ultrasound-driven bubble activities 
generated pores on the cell membrane that resulted in the intracellular delivery of PI and 
changes in [Ca
2+
]i. The correlated PI gain and fura-2 loss observed in cells due to 
ultrasound application indicated concentration-gradient driven, bidirectional transport 
characteristic of non-specific pores created by the sonoporation. Cells with delayed 
[Ca
2+
]i transients showed no PI uptake in cells, indicating calcium waves that originated 
from nearby sonoporated cells.  
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Chapter 3  
Dynamic Activities of Microbubbles Driven by Ultrasound Exposures Correlated 
with Delivery Outcomes by Sonoporation 
 
In this chapter, we describe the studies of correlating the microbubble activities 
driven by ultrasound exposures with sonoporation outcomes.  We implemented high 
speed video microscopy to investigate the dynamic activities of the Definity® 
microbubbles (Lantheus Medical Imaging, Billerca, MA) activities driven by various 
ultrasound exposures.  OptiCell™ (Nunc, Rochester, NY) was used to house the cells and 
microbubbles. We analyzed quantitatively the microbubble behaviors and established 
correlation of the bubble activities with the intracellular uptake using a model molecule 
propidium iodide (PI) and cell viability. These results provide a knowledge base to 
optimize sonoporation outcome. 
3.1 Introduction  
Ultra-fast photographs have provided insights to understand isolated single bubble 
behaviors near cells exposed to ultrasound pulses lasting a few microseconds [13, 14, 93, 
182, 183]. However, multiple bubbles subjected to longer ultrasound exposure (seconds), 
which are often used in studies employing sonoporation mediated intracellular delivery 
[3-7, 15-17], have not been investigated in detail. These investigations require controlled 
experimental environment for investigating microbubble dynamics and the resulting 
effects. Our approach to achieve enhanced intracellular delivery is by optimizing 
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ultrasound-driven microbubble interaction with cells, as it is the direct cause for any 
delivery outcomes, rather than ultrasound parameters.  
3.2 Materials and methods 
3.2.1 Cell culture 
Human umbilical vein endothelial cells (HUVEC) were cultured in flasks in 
complete human endothelial growth medium (Lonza CC-3124, Walkersville, MD) in a 
humidified incubator at 37˚C and 5% CO2. Before experiment, HUVEC cells were plated 
into OptiCell™ chamber (Nunc, Rochester, NY). HUVEC cells were cultured in the same 
medium in OptiCell™ for one more day. At the time of experiment, cells had reached 
approximately 90%-100% confluency. 
3.2.2 Assessments of delivery outcomes 
Intracellular uptake of propidium iodide (PI) (Sigma Aldrich, St. Louis, MO), 
which is cell membrane impermeable nucleic acid intercalating agent, was used to assess 
sonoporation. PI was dissolved in extracellular medium at the final concentration of 100 
μM. To detect PI, the specimen was excited at 539 nm, and emission was detected at 610 
nm. PI serves as a real-time cell membrane integrity indicator, as it only fluoresces after 
excitation when inside the cells. 
Cell viability was assessed by calcein AM assay. Calcein AM is a cell-permeable, 
non-fluorescent compound. In live cell, the non-fluorescent calcein AM is converted to 
green-fluorescent calcein, after acetoxymethyl ester hydrolysis by intracellular esterases. 
Calcein AM was dissolved in extracellular medium before ultrasound at the final 
concentration 1μM. To detect calcein signal, the specimen was excited at 488nm, and 
emission was detected at 520 nm. 
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3.2.3 Ultrasound exposure and microbubbles 
Ultrasound setup and microbubbles were the same as described in Chapter 2, 
shown in Fig.2-1. A range of ultrasound conditions was employed, with peak negative 
pressure from 0.06 MPa to 0.8 MPa, pulse repetition frequency (PRF) -from 10 hz to 1k 
hz-, duty cycles (DC) -from 0.008% to 20% - and a fixed total exposure time of 1 s. 
During each experiment, Definity® solution was diluted in complete culture medium for 
HUVEC with a final concentration ~10
7
 bubbles/ml. We used OptiCell™ cell culture 
chamber as  physical confinement for  Definity® microbubbles , so that microbubbles 
were in close contact with cells, which were attached on the inner upper membrane of 
OptiCell™, as illustrated in Fig.2-1C 
3.2.4 Optical imaging  
Bright-field imaging was performed to capture the microbubble activities driven 
by ultrasound using a high-speed camera (Photron FASTCAM SA1, San Diego, CA) 
with a frame rate 20,000 frames per second. To resolve the microbubble dynamics in 
microsecond scale, an ultra-fast camera (Specialised Imaging Multi-Channel Framing 
Camera SIM02, Herfordshire, UK) was employed with frame rate of 2,000,000 frame per 
second and exposure time of 100 ns.  
For fluorescence imaging, a monochromator (DeltaRAMX™ PTI, Birmingham, 
NJ) was employed to excite the samples at 539 nm for PI and 488 nm for Calcein.  The 
emission of specimen was filtered by a dichroic light filter (Chroma 52002, Rockingham, 
VT) with passbands of green and red. The fluorescent images were acquired with a 
cooled CCD camera (Photometrics QuantEM, Tuscon, AZ) and then artificially-colored 
using Matlab. 
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3.2.5 Data analysis 
The number of bubbles present in each frame was counted manually. For 
aggregates of bubbles, the bubble number in each cluster was estimated by dividing the 
projection area of the cluster by the averaged area of a single bubble cross-section. The 
percentage of bubbles number change in FOV was normalized by the number of bubbles 
prior to ultrasound application.  
To quantify the behavior of translation, a velocity threshold, 0.06 µm/µs, was 
empirically set to differentiate moving and non-moving bubbles. A bubble was 
considered as a moving bubble if at any time point during the entire 1s ultrasound 
exposure, its velocity was above this threshold. 
Delivery outcomes were assessed using two parameters: viability and delivery 
efficiency. For each ultrasound exposure, the fluorescent images of PI were acquired 
before and after ultrasound exposure, and calcein image was acquired post ultrasound for 
viability assessment. The total number of cells in the field of view (FOV) was considered 
as total number of cells. The percentage of calcein positive cell in the total cell number 
was defined as viability. The percentage of both PI and calcein positive cells (PI uptake 
and surviving cells) post ultrasound relative to all calcein positive cells (surviving cells) 
was defined as delivery efficiency.  
At each experimental condition, multiple experiments were conducted. The 
number of experiments are indicated where the results are reported. 
3.3 Results 
3.3.1 Characterization of the bubble dynamics correlated with sonoporation 
outcomes 
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In our experiments, we have observed that different ultrasound parameters lead to 
different complex bubble dynamics and usually a mixture of bubble behaviors. To 
elucidate the correlation between bubble dynamics and sonoporation outcomes, bubble 
dynamics driven by a wide range of ultrasound conditions in entire FOV were 
quantitatively analyzed and categorized.  
Three basic categories of bubble behaviors were identified from detailed 
examination of the bubble behaviors in this study: category 1, aggregation and 
microstreaming; category 2, violent translation; category 3, rapid collapse. Typical 
examples for each category are shown in Fig.3-1, Fig.3-3, and Fig.3-5. In each figure, 
part A provides an overview of the bubble activities before, during and post ultrasound 
exposure, followed by PI images before and post ultrasound and calcein image post 
ultrasound as the assessments of small molecule delivery outcome and cell viability. Part 
B and C provide details of a particular kind of bubble behavior. Ultrasound was switched 
on at time 0.  
Driven by low acoustic pressure and relative long DC (0.06 MPa, 20 hz PRF, 
20% DC, 1 s ultrasound applied for data shown in Fig.3-1), aggregation of bubbles 
(Fig.3-1A and B) and microstreaming built up by relatively big bubbles (Fig.3-1C) were 
often observed. Attracted by nearby bubbles, small bubbles gradually moved to get 
together to form small bubble clusters. As long as ultrasound was on, small bubble 
clusters can further attracted by nearby cluster to aggregate into bigger cluster (Fig.3-1B). 
Originating from the oscillation of a relatively big bubble, microstreaming was built up in 
the fluid around it, which was illustrated by the trajectories of its surrounding small 
bubbles carried by the microstreaming flow (Fig.3-1C). Figure 3-1C also shows that this 
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oscillating big bubble was poking the membrane of the adjacent cell. However, this 
aggregation and microstreaming bubble activities did not have any impact on PI uptake 
or cell viability as shown in Fig.3-1A. 
 
Figure 3-1 A typical example of Definity® microbubbles behavior category 1: aggregation and 
microstreaming. In this example, Definity® microbubbles were suspended in OptiCell™, driven 
by 1M hz transducer, with 0.06 MPa, 20 hz PRF, 20% DC (10 ms in each pulse), 1s exposure 
totally. Panel (A) shows selective bright field images of a 216 μm180 μm area before, during 
and immediately post ultrasound application, followed by fluorescence images excited at 538 nm 
before and post ultrasound for PI signals, and fluorescence images excited at 488 nm for calcein 
signal post ultrasound. Two sub-areas are selected in panel (A), labeled as (B) and (C), showing 
microbubbles aggregation and microstreaming respectively. More temporal information was 
shown in panel (B) and (C) accordingly. 
 
In order to quantitatively describe the bubble dynamics in the data shown in 
Fig.3-1, we measured two parameters: the total bubble number change in FOV as a 
function of time and cluster size before ultrasound and at 1s (Fig.3-2).  As shown in 
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Fig.3-2A, there was no significant bubble number change over 1s ultrasound exposure. 
While aggregation was demonstrated by the growth of cluster size shown in Fig.3-2 B. 
Before ultrasound, microbubbles were evenly distributed in the FOV, as 160 bubbles out 
of 175 bubbles were individual bubbles without touching with any other bubbles. By 
comparison, after 1s ultrasound exposure, many bubble clusters formed, with bubbles 
number per cluster varying from 2-37(Fig.3-2 B). 
 
Figure 3-2 Quantitative analysis of Definity microbubbles dynamics in the data shown in Fig.3-1. 
(A) Total bubble number change in the FOV as a function of time over 1s ultrasound exposure. 
(B) Histogram of cluster size before ultrasound and at 1s.  
 
With much higher acoustic pressure and long DC, the second category of bubble 
dynamics: coalescence and translational movements were results, as shown in Fig.3-3 
(0.43 MPa, 20 hz PRF, 20% DC (10ms in each pulse), 1 s ultrasound was applied to the 
data shown in Fig.3-3). Once ultrasound was on, bubble coalesced right the way. Small 
bubbles coalesced into big bubbles; big bubbles further coalesced into even bigger 
bubbles (Fig.3-3B). Due to this strong attraction between bubbles, coalescence was 
accompanied with violent translation. The coalesced big bubbles crazily moved around 
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while wildly oscillating, intruding into cells on its pathway, tearing apart cell membranes, 
and forcing cells detach from the bottom immediately (Fig.3-3A and C). This violent 
translation movement was devastating to the cells on their pathway, resulting in massive 
cell death immediately after ultrasound exposure (Fig.3-3A). Although the total 
ultrasound duration applied for data shown in Fig.3-3 was 1 second, all microbubbles 
disappeared once the 1
st
 ultrasound pulse was off, making all the following ultrasound 
pulses useless in terms of delivery outcomes. 
 
Figure 3-3 A typical example of Definity® microbubbles behavior category 2: coalescence and 
translation. In this example, Definity® microbubbles were suspended in OptiCell™, driven by 
1Mhz transducer, with 0.43 MPa, 20 hz PRF, 20% DC (10 ms in each pulse), 1s exposure totally. 
(All bubble disappeared immediately after 1
st
 ultrasound.) Panel (A) shows selective bright field 
images of a 216 μm180 μm area before, during and immediately post ultrasound application, 
followed by fluorescence images excited at 538 nm before and post ultrasound for PI signals, and 
fluorescence images excited at 488 nm for calcein signal post ultrasound. Panel (B) and (C) are 
sub-areas shown in the image of Panel (A), with more temporal information, illustrating 
coalescence in (B) and newly fused big bubble fast translating while violently oscillating in (C).   
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 In order to quantitatively describe the bubble dynamics in the data shown in 
Fig.3-3, we measured two parameters: the total bubble number in FOV as a function of 
time and the percentage of moving bubbles in FOV as a function of time, shown in Fig.3-
4. The time periods shown in Fig.3-4 were from -0.5ms up to 10ms, as after 1 ultrasound 
pulse (10ms) no bubble existed any more. There was a sudden drop of bubble number 
within the first 0.05ms (from 250 to 170), which may be due to collapse and coalescence 
happened once ultrasound was on. After that, the residual bubbles were oscillating driven 
by on-going ultrasound and gradually shrinking, which may be due to passive diffusion; 
while the coalesced big bubbles were moving around fast and absorbed/fused with small 
bubbles along their moving paths. These may explain the gradual decreasing of bubble 
number between 0.5ms to10ms, shown in Fig.3-4A. Once ultrasound was turn off at 
10ms, all bubble immediately disappeared.    
 
Figure 3-4 Quantitative analysis of Definity microbubbles dynamics in the data shown in Fig.3-2.  
(A) Total bubble number change in FOV as a function of time over 10ms. (B) Percentage of 
moving bubble change as a function of time over 10ms. 
 
A B 
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 High pressure with very short pulse duration created the third bubble dynamics 
case, rapid collapse. As typical example shown in Fig.3-5A (0.43 MPa, 10 hz PRF, 
0.008% DC (8 μs in each pulse), 1 s ultrasound was applied to data shown in Fig.3-5A), 
with minimal translational movement, bubble size gradually decreased during ultrasound 
exposure. The sonoporation outcomes show that there were some cells exhibiting PI 
uptake and surviving. As the ultrasound only lasted 8 μs, 20,000 fps frame rate is not 
sufficient to resolve the details during ultrasound-on time; therefore ultra-fast camera was 
applied to supplement the details information. Figure 3-5 (B-D) are ultra-fast images of 
Definity® microbubbles in Opticell without cell attached, driven by 0.43MPa, 8μs 
ultrasound.  The images were captured at 2M frames per second, 100 ns exposure time. 
Figure 3-5 B-D illustrates three different bubble behaviors: oscillation (Fig.3-5B), 
microjet formation (Fig.3-5C) and fragmentation (Fig.3-5D). The direct observation of 
Fig.3-5C is vortex ring formation, which indicating a flow is penetrating the center of the 
ring, which is microjet. 
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Figure 3-5 A typical example of Definity® microbubbles behavior category 3: collapse. In this 
example, Definity® microbubbles were suspended in OptiCell™, driven by 1Mhz transducer, 
with 0.43MPa, 10 hz PRF, 10 μs (10 cycles) in each pulse, 1 s exposure totally. (All bubble 
disappeared after 4
th
 ultrasound pulse.) Panel (A) shows selective bright field images of a 257 
μm184 μm area before, post 1st ultrasound pulse, followed by fluorescence images excited at 
538 nm before and post ultrasound for PI signals, and fluorescence images excited at 488 nm for 
calcein signal post ultrasound. Panel (B-D) are ultrasound excited Definity® microbubbles 
images captured by ultra-fast camera with frame rate 2M fps, showing three different bubble 
activities during ultrasound exposure, oscillation (B), forming microjet (C) and fragment (D). The 
direct observation of panel (C) is vortex ring formation, which indicating a flow is penetrating the 
center of the ring, which is microjet. The time label and scale bar in (B) apply for (C) and (D). 
 
In order to quantitatively describe the bubble dynamics in the data shown in 
Fig.3-5, we measured two parameters: the total bubble number change in FOV as a 
function of time and the percentage of moving bubbles change in FOV as a function of 
time, shown in Fig.3-6A-B. In addition, the radius change of a typical bubble in FOV was 
shown in Fig.3-6 C.  It is shown in Fig.3-6 A that ultrasound pulse immediately destroyed 
B 
C 
D 
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some bubbles, resulting into the sudden drop right after each ultrasound pulse. 
Meanwhile, some bubbles gradually disappeared during the ultrasound-off interval, 
which may be owing to diffusion, especially in the case when lipid shell of microbubbles 
was broken by ultrasound. Only when ultrasound was on, bubbles moved, but the 
percentage of moving bubbles (Fig.3-6B) was significantly lower than in category 2 
(Fig.3-4B), as each ultrasound pulse only lasted 8μs. Before a bubble completely 
disappeared, usually it experienced shrinking during ultrasound on and off period. A 
typical example of a bubble size evolution was shown in Fig.3-4C. 
 
Figure 3-6 Quantitative analysis of Definity microbubbles dynamics according to the example 
shown in Fig.3-5. (A) Total bubble number change as a function of time. (B) Percentage of 
moving bubbles changes as a function of time. (C) Radius change as a function of time of a 
bubble in this data.   
 
Detailed descriptions of typical examples in each category ware presented above, 
systematic analysis and correlation with bubble dynamics and sonoporation outcome with 
statistic power was conducted as followed. As shown in the quantitative bubble dynamic 
C 
B A 
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analysis that immediately after 1s ultrasound exposure, 96% bubbles still exist in the 
example for category 1 (Fig.3-2B, the data with 20 hz PRF); while 0% and 0% bubble 
exist in the examples of category 2 (Fig.3-4B, the data with 20 hz PRF) and 3 (Fig.3-6, 
the data with 10 hz PRF). Collapsing is a main reason decreasing bubble number. 
Therefore, the percentage of bubbles remaining in the FOV immediately after 1 s 
ultrasound exposure can serve as a good indicator to distinguish category 1 from category 
2 and 3. Another indicator to differentiate category 2 and 3 is the number of moving 
bubbles during ultrasound-on time. Moving is defined as the displacement between 2 
consecutive frames is larger than 6 pixels. Driven by much longer pulse in category 2 
compared with category 3, the percentage of moving bubbles in category 2 was 
significantly larger than category 3. 
Under the ultrasound conditions which created the three basic bubble dynamics 
categories, more data were collected and presented in Fig.3-7. For category 1, ultrasound 
applied was 0.06MPa, 20hz PRF, 20% duty cycle, 1s; for category 2, ultrasound applied 
was 0.43MPa, 20hz PRF, 20% duty cycle, 1s; and for category 3, ultrasound applied was 
0.43MPa, 10hz PRF, 0.008% duty cycle, 1s (Fig.3-7). Bubble dynamics was indicated by 
“% of bubble remaining at 1s” and “% of moving bubbles” (Fig.3-7A). The 
corresponding sonoporation outcomes, including viability and delivery efficiency are 
shown in Fig.3-7B. Clearly shown in Fig.3-7B, these three categories have distinctive 
characteristic sonoporation outcomes, while category 3 has the most desirable outcomes, 
viability 88±6% (N=9) and delivery efficiency 37±6%. By comparison, category 1 has 
zero delivery efficiency, and the viability for category 2 is poor (24.1±8.6%, N=10). 
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Figure 3-7 Bubble dynamics characterization (A) and the corresponding PI delivery outcomes (B) 
under the ultrasound conditions creating the basic three categories: Cat.1 Aggregation and 
microstreaming (US: 0.06MPa, 20hz PRF, 20% duty cycle, 1s); Cat.2. Coalescence and 
translation (US: 0.43MPa, 20hz PRF, 20% duty cycle, 1s); and Cat.3. Collapse (US: 0.43MPa, 
10hz PRF, 0.008% duty cycle, 1s). Viability is defined as the number of surviving cells divided 
by the total number of cells in the FOV. Delivery efficiency is defined as the number of surviving 
and PI uptake cells divided by the total number of cells in the FOV. “N” is the number of 
experiments conducted. 
 
3.3.2  Mapping sonoporation outcomes with bubble dynamics 
Since sonoporation outcomes is directly determined by the bubble dynamics, and 
three typical bubble dynamics categories and their sonoporation outcomes have been 
characterized; Figure 3-8 shows that bubble dynamics and sonoporation outcomes of four 
data sets were mapped in the coordinate established by the three typical categories. 
Starting from data set 1 (0.1 MPa, 20 hz PRF, 20% DC, 1s ultrasound applied), whose 
bubble dynamics and sonoporation outcomes are very similar to categoery1, as the 
bubble dynamic of data set 2, 3 and 4 are approaching category 2 and category 3, their 
delivery efficiency increases while viability decrease.  Compared with data set 2 (0.12 
MPa, 20 hz PRF, 10% DC, 1s ultrasound applied), data set 3 (0.23 MPa, 20 hz, 0.4% DC 
(200 μs in each pulse), 1 s ultrasound applied) is closer to category 3 in the bubble 
dynamics coordinate, as a result, shown in sonoporation outcome coordinate, data set 3 
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exhibits higher delivery efficiency than data set 2. Compared with data set 3, the bubble 
dynamic of data set 4 (0.23 MPa, 20 hz PRF, 20% DC, 1s ultrasound applied) is located 
nearer to category 2, which features low viability, therefore data set 4 displays lower 
viability than data set 3. These four data sets can be seen as a mixture of the typical 
categories. Among all the bubble dynamic groups, three typical ones, and four mixtures, 
category 3 “rapid collapse” shows its superior delivery efficiency, confirming that it is 
the preferable scenario for intracellular delivery. 
 
Figure 3-8 Mapping bubble dynamics (A) and sonoporation outcomes (B) of 4 data sets using the 
typical three categories as landmarks. The ultrasound condition for the 4 data sets are: Data set1:  
0.10 MPa, 20 hz PRF, 20% DC, 1 s (N=4); Data set 2: 0.12 MPa, 20 hz PRF, 10% DC, 1s (N=8); 
Data set 3: 0.23 MPa, 20 hz, 0.4% DC (200 μs in each pulse), 1 s (N=4); and Data set 4: 0.23 
MPa, 20 hz PRF, 20% DC, 1 s (N=4). 
 
3.3.3 Effects of ultrasound parameters on bubble dynamics  
Bubble dynamics is resulted from all ultrasound parameters, including transducer 
center frequency, acoustic pressure, PRF, DC, total duration, in addition to the specific 
chemical and physical condition in a certain experimental setup. Figure 3-9 provides a 
hint about how ultrasound parameters impact the microbubble dynamics. With very short 
pulse duration 10 μs, increasing acoustic pressure, bubble dynamics gradually transited 
from category 1 to category 3, while the moving bubble slightly increased as well (Fig.3-
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9A). And with relative long pulse duration (10ms), increasing acoustic pressure, bubble 
dynamics gradually transited from category 1 to category 2 (Fig.3-9B). The percentage of 
both the destroyed bubble and moving bubbles increase with increased acoustic pressure 
(Fig.3-9B). Other ultrasound parameters, such as PRF, also take effects, as shown in 
Fig.3-9C and D. With fixed DC, lower PRF lead to more moving bubbles (Fig.3-9C) and 
with fixed pulse duration, higher PRF lead to more moving and destroyed bubbles (Fig.3-
9D).  
In a certain experiment configuration, ultrasound conditions determine bubble 
dynamics, and bubble dynamics determine delivery outcomes. Therefore we intended to 
build the connection between ultrasound conditions, bubbles dynamics and delivery 
outcomes. Figure 3-10 shows how acoustic pressures and duty cycles affect bubble 
dynamics with 20hz PRF. The three basic categories of bubble dynamics were indicated 
on the plot. The delivery outcomes responding to the three basic categories have been 
characterized (Fig.3-7). The bubble dynamics generated by different ultrasound 
parameter combinations can be seen as the mixture of the three basic categories. 
Therefore, by comparing the bubble dynamics with the basic categories, its delivery 
outcomes can be estimated qualitatively.   
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Figure 3-9 Impact of ultrasound parameters, including acoustic pressure (A and B) and PRF (C 
and D) to bubble dynamics 
 
 
Figure 3-10 Impact of ultrasound parameter (acoustic pressure and duty cycle) to bubble 
dynamics. Bubble dynamics were characterized by % of remaining bubble at 1s (A) and % of 
moving bubbles (B).0.008% duty cycle data were with 10hz PRF. All other data were with 20hz 
PRF. 
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In short, bubble dynamics is determined by all ultrasound parameters along with 
all other experimental factors. This knowledge inspirits us in two perspectives. One is 
that the phenomenal association built up between certain ultrasound parameters and 
delivery outcomes without knowing bubble dynamics is isolated information and may not 
apply in a different experimental setting. Another is that the rational approach to promote 
the sonoporation delivery results is to optimize microbubble activities relative to cells.  
3.4 Discussion 
3.4.1 Sonoporation correlated with bubble dynamics  
In this study, we conducted experiments using Definity® microbubbles in 
OptiCell™ configuration. The critical role of ultrasound-driven microbubbles in this 
setting was explicitly demonstrated by quantitative analysis of the dynamics process and 
precise spatiotemporal correlation with outcomes assessments. Three basic bubble 
dynamics categories have been identified: aggregation and microstreaming (category 1), 
coalescence and translation (category 2) and rapid collapse (category 3); while category 3 
shows the most favorable delivery outcomes. The broad relevance of bubble dynamics 
permits mapping others’ studies performed in a similar experimental setup using the 
bubble dynamics coordinate built up in this study. For example, van Wamel et al [97] 
provided bright field images. The bubble dynamics in their experiment can be classified 
into category3. And their results confirmed that category 3 has the high delivery 
efficiency while good viability.   
We built up a whole perspective of microbubble mediated sonoporation: bubble 
dynamics in the key position determining sonoporation outcomes and determined by 
ultrasound parameters. The ultrasound parameter studies, highly depending on the initial 
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protocol to start with, they are easily restricted themselves in a narrow bubble dynamics 
region, losing the whole picture of bubble dynamics, and therefore finding a local optimal 
condition. Rahim et al. [144]  found that the optimal ultrasound condition is 0.25 MPa 
peak negative pressure with 40 cycles/pulse, with delivery efficiency 4%. However, the 
bubble dynamics they explored is most likely close to category 1. They did not explore 
the cateogery3, which might give them dramatically higher delivery efficiency. 
Moreover, it’s not surprising that contradictory results can arise with the respect of 
ultrasound parameter on sonoporation outcomes. For example, the impact of duty cycles 
were reported making no difference [144] or being critical [184] on delivery efficiency. 
This inconsistency can be easily explained as the bubble dynamics of these two studies 
were in different categories. The bubble dynamics in Rahim’s study [144]  and 
Merjering’s study [184] most likely close to category 1, and category 2 respectively.  
3.4.2 High speed imaging and ultra-fast imaging  
While ultra-fast speed photographs can capture expansion and contraction of an 
oscillating bubble or the evolution of a collapsing bubble with frame rate from 0.5M fps 
to 10M fps [13, 56, 93, 95-97, 185], our high speed camera are able to continuously 
record the dynamic process of bubble-cell interaction during entire 1s pulsed ultrasound 
exposure and reveal some relatively slow process, such as microstreaming and violent 
translation. Because of the continuity of ultrasound-driven bubble activities, the 
observation at the shutter duration on the order of nanoseconds ([13, 56, 93, 95-97, 185]) 
and the observation at the shutter duration at 50 microseconds (this study) are mutually 
complementary, as shown in Fig.3-1, Fig.3-3, and Fig.3-5. All these direct optical 
observation shows many different kinds of bubble behaviors. The driven force for these 
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behaviors may be different. The movement in the direction of ultrasound propagation is 
due to the primary radiation force, while the attraction or repulsion between bubbles is 
due to the secondary radiation force [93, 100, 108, 186].  
3.4.3 Biologic relevance besides intracellular delivery 
Though some bubble behaviors, such as aggregation and mild oscillation, are not 
inducing intracellular delivery, they may have other therapeutic applications. Microfoam 
formation in capillary due to aggregation has been studied and suggested to be used to 
block the entire vessels on purpose [187]. At very low intensity of ultrasound exposure, 
mild oscillation was demonstrated to increase calcium ion permeability, intracellular 
H2O2 level, protein nitrosylation, rearrangement of F-actin cytoskeleton, as well as 
reversible change of monolayer integrity, which was suggested to have potential 
application in control gene expression and trigger vascular angiogenesis [126]. Mild 
translation can be used to displace targeted contrast agents to a vessel wall, increasing 
binding efficiency between targeted contrast agents and available surface receptors for 
ultrasonic molecular imaging [188]. 
3.4.4 Different experimental setting results in different bubble dynamics 
In this study, experiments were performed in an OptiCell™ cell chamber, where 
bubbles are in close proximity of cells before ultrasound. Therefore, the specific 
knowledge about bubble dynamics categorization is limited in a similar setup. A lot of in 
vitro sonoporation studies were conducted in dishes or tubes with cell suspension [15, 
115, 189]. In this case, long-time translational movement of bubbles may be desirable, as 
it can create streaming flow, carrying bubbles to the close vicinity of cells. In addition, in 
the case, where delivery efficiency was considered in the larger area, for example, entire 
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OptiCell™ chamber, long-time ultrasound exposure may be required, as with increased 
exposure time, larger area will be affected. Nevertheless, the key principle we proposed 
here is applicable for all setups, which is the bubble dynamics play the key role in 
sonoporation study, as a bridge, connecting all ultrasound parameters and sonoporation 
outcomes.  
3.5 Conclusion 
In this study, microbubble dynamics in a large population exposed to 1s pulsed 
ultrasound have been thoroughly explored. After observing various bubble dynamics, 
three basic bubble dynamics categories have been identified. Bubble dynamics and 
corresponding delivery outcomes in three basic categories have been quantified and 
characterized. Category 3 “rapid collapse” can result in the optimal delivery outcomes. 
Finally we intended to build up the connection between ultrasound parameters and 
delivery outcomes bridging with bubble dynamics. These results provide insight in 
interpreting sonoporation outcomes in different experimental environments and 
ultrasound conditions. And more importantly, it built a knowledge base to guide 
optimization of bubble-cell interaction so that enhanced delivery outcomes can be 
achieved.  
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Chapter 4  
Controlled and Enhanced Delivery Facilitated by Targeted Microbubbles 
Interaction of ultrasound-driven microbubble with cells is the direct cause for 
intracellular delivery by sonoporation. In previous chapter we identified that the rapid 
collapse of microbubble, provides the highest uptake while maintaining good cell 
viability.  
In this chapter, we describe our studies which utilized targeted microbubbles to 
further increase the controllability of microbubbles and their interaction with cells. By 
manipulating targeted microbubbles activities with optimized ultrasound exposure 
conditions, we achieved improved gene transfection outcomes. 
4.1 Introduction  
Targeting ligands attached to the lipid, protein or polymer shell coating of gas-
filled microbubbles, can guide microbubbles specifically land on the cell surface where 
the targeted receptors are expressed [52, 72]. The rapid progress of targeted microbubble 
engineering in recent years is promoted by the general aims of spatial visualization of 
molecular markers of diseases, such as thrombosis, inflammation, ischemia/reperfusion 
injury, angiogenesis and related conditions [72, 190]. It can also function as specific and 
local drug and gene delivery carrier and booster both for in vivo and in vitro applications 
[12, 191, 192].  
4.2 Materials and methods 
4.2.1 Cell culture 
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Human Embryonic Kidney (HEK-293) cells were provided by Dr. Y. Eugene 
Chen (University of Michigan). Before experiments, the cells were grown in flasks in a 
humidified incubator at 37˚C containing 5% CO2 in DMEM supplemented with 10% fetal 
bovine serum and 1% penicillin-streptomycin. Human umbilical vein endothelial cells 
(HUVEC) were maintained in flasks in complete human endothelial growth medium 
(Lonza CC-3124, Walkersville, MD) in a humidified incubator at 37˚C and 5% CO2. For 
all experiments, cells were seeded in fibronectin coated 20 mm-diameter-glass-bottom 35 
mm petri dish (MatTek, Ashland, MA, USA) one day before experiments. At the time of 
experiment, cells had reached approximately 90%-100% confluency. 
Rat aortic smooth muscle cells (RASMC) were used for gene transfection. 
RASMC were maintained in flasks in complete growth medium consisting of 
DMEM/F12 (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum and 
1% penicillin-streptomycin in a humidified incubator at 37˚C and 5% CO2. Before 
experiment, cells were plated in fibronectin coated 20 mm-diameter-glass-bottom 35 mm 
petri dish. Cells were cultured in the same medium for 18~24 hours. Cells were 
approximately 80% confluent by the time of gene transfection experiment.  
4.2.2 Preparation of microbubbles 
Targestar™-SA (Targeson, La Jolla, CA) are microbubbles composed of a 
perfluorocarbon gas core encapsulated by a lipid shell. The outer shell is derivatized with 
streptavidin, which can bind biotinylated ligands. The suspension in glass vial is at a 
concentration of approximately 1x10
9 
microbubble/ml with a median diameter of 2.5 μm. 
Biotinylated anti-human CD51 antibody (Biolegend, City, State, USA) for targeting HEK 
cells; biotinylated anti-human CD31 antibody (eBioscience, San Diego, CA) for targeting 
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HUVEC cells; and biotinylated anti-mouse CD51 antibody (BioLegend, San Diego, CA) 
antibody for targeting RASMC were used respectively . 
8 μl of targeted microbubbles stock solution (1x109  bubble/ml) was mixed with 2  
μl of antibody (stock solution with concentration 0.5 mg/ml) and incubated for 20 min at 
room temperature then diluted into 490 μl DPBS (Invitrogen, Carlsbad, CA). The diluted 
solution has microbubble concentration of 1.6x10
7 
microbubbles/ml, and antibody 
concentration of 2 μg/ml. Before binding antibody conjugated microbubbles to cell 
surface, culture medium in glass-bottom dish was completely removed first. 20 μl of 
diluted solution, which contained 3.2x10
5
 microbubbles, and 0.04 μg of antibody, was 
added onto cells attached to the glass bottom of a petri dish. And then the petri dish was 
flipped over and incubated at room temperature for 10 minutes. Finally the dish was 
flipped back and gently washed with DPBS to remove unbound microbubbles. 
4.2.3 Plasmid labeling and transfection  
For ultrasound mediated gene transfection, pmaxFP™-Green-C plasmid (Lonza, 
Walkersville, MD), encoding green fluorescent protein (GFP), was added to extracellular 
medium (DPBS) at the final concentration of 10 μg/ml before ultrasound exposure. 10 
minutes after ultrasound exposure, the medium was discarded and replaced with fresh 
complete culture medium. The GFP expression was analyzed after 24 hours incubation. 
To visualize the plasmid, plasmid was fluorescently labeled by nucleic acid stain 
fluorophore BOBO™-3 iodide (Invitrogen, Carlsbad, CA). BOBO™-3 iodide is non-
fluorescent itself, after binding with double strands nucleic acid, it shows strong orange 
fluorescence, with the maximum excitation wavelength of 570 nm and maximum 
emission of 602 nm. To label plasmid, BOBO™-3 iodide was mixed with plasmid at the 
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molecule ratio of 1 dye molecule per 30 base pairs for 30 minutes in room temperature in 
dark.  
Ultrasound mediated gene transfection was compared with lipofection, using 
lipofectamine 2000 (Invitrogen, Carlsbad, CA). Lipofectamine 2000 and plasmid were 
added to extracellular medium at the ratio of 1/1 (w/v). Cells were incubated in this 
medium for four hours and then the medium was discarded and replaced with fresh 
complete culture medium. The GFP expression was analyzed after 20 hours later.  
4.2.4 Experimental setup and ultrasound application  
The 35 mm petri dish was placed on the stage an inverted microscope (Nikon 
Eclipse Ti-U, Melville, NY). A 1.25 Mhz single element planar transducer (Advanced 
Devices, Wakefield, MA) was used for all experiments. The experiment setup was the 
same as described in Chapter 2, shown in Fig.2-1A, except that the OptiCell™ cell 
culture chamber was replaced by a 35mm petri dish. During the experiments, the 
transducer was mounted above the petri dish, angled at approximately 45˚ and its active 
surface submerged in extracellular medium in a petri dish 7.5 mm away from the cell 
surface. The transducer was driven by a function/waveform generator (Agilent 
Technologies 33250A, Palo Alto, CA) and a 75 W power amplifier (Amplifier Research 
75A250, Souderton, PA). The transducer was characterized in free field using computer-
controlled system with a 40 μm calibrated needle hydrophone (Precision Acoustics 
HPM04/1, UK). Different ultrasound conditions were employed, with peak negative 
pressure from 0.06 MPa to 2 MPa, PRF 10 or 20hz, DC from 0.008% to 20%, total 
exposure time from 8 μs to 1 s. For gene transfection, multiple pulse mode was used, 
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which consisting of 1-3 ultrasound pulses with increased pressure (1.6 MPa, 1.8 MPa and 
2 MPa) with time interval 0.05 s. 
4.2.5 Optical imaging  
Microbubble activity in bright field driven by ultrasound was captured by a high-
speed camera (Photron FASTCAM SA1, San Diego, CA) with frame rate 20,000 frames 
per second. Propidium iodide (PI) was used as an intracellular delivery marker, and 
fura2-AM was used to monitor intracellular free calcium ([Ca
2+
]i), which are the same as 
described in Chapter 2 and 3. After 2 excitation channels recording of fura2 fluorescent 
signals (at 340 nm and 380 nm), pseudo-colored ratio image of [Ca
2+
]i were generated 
using MetaFluor Analyst (Molecular Devices, Downingtown, PA) and MATLAB 
(Mathworks, Natick, MA) following the same protocol described in Chapter 2. For 
fluorescent images, a monochromator (DeltaRAMX™ PTI, Birmingham, NJ) was 
employed to excite the samples at various wavelengths according to fluorophores. The 
fluorescent images were collected using a cooled CCD camera (Photometrics QuantEM, 
Tuscon, AZ) and then artificially-colored using Matlab or a color camera (QIMAGING 
Micropublisher 5.0, Surrey, BC, Canada).  
4.2.6 Data analysis 
Sonoporation delivery outcomes were assessed by viability (calcein AM assay), 
intracellular PI delivery efficiency and delivery amount (PI intensity). For each 
ultrasound application, the fluorescent images of PI were acquired before and after 
ultrasound exposure, and calcein image was acquired post ultrasound. The total number 
of cells with bubble attached in the FOV was considered as total cell number. The 
percentage of calcein positive cell in the total cell number was defined as viability. 
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Within total cells, the percentage of both PI and calcein positive cells (PI uptake and 
surviving cells) post ultrasound relative to all calcein positive cells (surviving cells) was 
defined as delivery efficiency. PI intensity was quantified in PI uptake and surviving cells 
using ImageJ software. The cell’s contour was manually defined based on calcein image 
and applied to background corrected PI image. Spatially averaged red intensity was 
defined as PI intensity in this cell in arbitrary unit. 
The ultrasound mediated gene transfection efficiency was examined 24 hours 
after ultrasound. The 6 dB band width of the 1.25 Mhz transducer with 10 cycles is 4 
mm. Therefore, a 4 mm  4 mm area was marked on the bottom of petri dish centered at 
the transducer aimed spot right after ultrasound exposure. After 24 hours, the percentage 
of GFP positive cells relative to the estimated total number of cells, which had bubbles 
attached before ultrasound, within this area was defined as transfection efficiency. The 
percentage of cells with bubble attached before ultrasound was calculated using the bright 
field image taken before ultrasound. This percentage was multiplied with the total cell 
number counted in this 4 mm4 mm area 24 hours later. The result was used asthe total 
number of cell, which had bubbles attached before ultrasound. In each 35 mm petri dish, 
2 to 3 ultrasound exposures were applied. The lipofection efficiency was examined 24 
hours since experiments started, including 4 hours incubation with lipofectamine2000 
and plasmid, and 20 hours incubation with fresh growth medium. In each dish, 3 areas 
with 4mmx4mm were arbitrarily chosen to calculate the percentage of GFP positive cells 
relative to the total cell number in this area.   
At each experimental condition, multiple experiments were conducted. The 
number of experiments are indicated where the results are reported. 
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4.3 Results 
4.3.1 Controlled delivery by targeted microbubbles 
Multiple entry areas were generated when multiple bubbles attached on one cells, 
and multiple excitations were created when multiple ultrasound pulses were applied. As 
shown in Fig.4-1A, two bubbles were positioned on the two ends of a cell, which resulted 
into two entry spots of PI (Fig.4-1B) and [Ca
2+
]i (Fig.4-1C) transients simultaneously. 
The PI intensity at two spots was at the same level, which may be due to the similar size 
of the bubbles and similar intracellular RNA distribution at two spots. As long as the 
microbubble was not completely destroyed, it could respond to the following ultrasound 
excitation. The example shown in Fig.4-2 illustrates that PI uptake and [Ca
2+
]i transient 
was created at time 0, when first ultrasound (0.17 MPa and 2.4 μs) was applied; while PI 
uptake and [Ca
2+
]i transient was created again at time 470 s, when a second ultrasound 
(0.23 MPa and 2.4 μs) was applied. The insert of Fig.4-2A shows a bright field image 
before ultrasound and superimposed with PI image at time 11 s, indicating there was a 
microbubble attached on the left side of the cells, and PI entranced from the bubble 
attached area. The selective PI images and pseudocolor [Ca
2+
]i images shown in Fig.4-2B 
presenting multiple PI uptake and multiple [Ca
2+
]i changes. 
 
 
70 
 
 
Figure 4-1 Multiple targeted microbubbles attached on cell membrane (A) resulted multiple entry 
area of PI (B) and Ca
2+ 
(C). Ultrasound applied was of 0.17 MPa and 2.4 μs duration. 
 
 
Figure 4-2 Multiple excitations of ultrasound pulses induced multiple entry of PI and Ca
2+
 at 
different time. (A) [Ca
2+
]i change, indicated by ratio of 340 nm excitation and 380 nm excitation, 
and PI intensity change as a function of time. Insert is a bright field image before ultrasound 
superimposed with PI fluorescent image at time 11s. Scale bar is 10 μm. (B) Selective fluorescent 
images of PI (first row) and pseudocolor [Ca
2+
]i images. The first ultrasound pulse was of 0.17 
MPa and 2.4μs duration, and second pulse was of 0.23 MPa and 2.4 μs duration. 
 
Microbubbles with different initial size respond to the same ultrasound exposure 
differently. Because of the close distance between bubbles and cell membrane, the 
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difference of microbubbles response are very likely translated into the difference of cell 
membrane deformation and thereby delivery outcomes. On the other hand, selective 
excitation of microbubbles depending on their initial size can be used as a strategy to 
achieve staged delivery outcomes.  Under the same ultrasound excitation (0.29 MPa and 
5 μs in Fig.4-3), typical images illustrates that bubbles with larger initial radius exhibited 
larger maximum radius during expansion (Fig.4-3A). From the measurement of 24 
bubbles under this ultrasound condition, it shows that the maximum radius during 
expansion is linearly related with the initial radius (R
2
=0.87) (Fig.4-3B). The results from 
Fig.4-3 imply that excited by the same ultrasound, bigger bubbles may results larger cell 
membrane deformation and therefore more uptakes compared with smaller bubbles. To 
more effectively stimulate small bubbles, stronger acoustic pulse may be needed. This 
principle was demonstrated in Fig.4-4. Upon the first ultrasound pulse (0.26 MPa and 8 
μs) at time 0, the bigger bubble (bubble 1, 2μm radius) was successfully excited and lead 
PI uptake into cell1 while the smaller bubble (bubble 2, 1.5μm radius) did not change 
much and resulted no PI uptake. A second pulse with higher pressure (0.6 MPa and 8 μs) 
was applied at time 250 s and effectively excited bubble 2 and resulted in PI uptake into 
the cell. Staged delivery was achieved by selective excitation of microbubbles with 
different initial size. 
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Figure 4-3 Maximum bubble radius during expansion is correlated with bubble initial size, under 
a certain ultrasound condition. (A-C) Ultra-fast images of Definity® microbubbles with different 
initial radius (1.9 μm, 3.1 μm and 5.3 μm) were excited by 0.29 MPa and 5 μs ultrasound. (D) 
Scatter plot of maximum bubble radius during expansion as a function of initial radius (n=24) 
excited by 0.29 MPa and 5 μs ultrasound. A linear fitting was applied, with the goodness of 
fitting R
2
=0.87. 
 
Figure 4-4 Excitation of microbubbles with different radius by different ultrasound pressure to 
achieve staged delivery. Before ultrasound, bubble 1 was of 2 μm radius and bubble 2 was of 1.5 
μm radius. The first ultrasound (0.26 MPa and 8 μs) was applied at time 0 s, anther ultrasound 
pulse (0.6 MPa and 8 μs) was applied at time 250 s.  
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4.3.2 Comparison of bubble dynamics between targeted and non-targeted 
microbubbles 
The three basic categories of Definity® microbubble as non-targeted 
microbubbles were investigated in-depth in Chapter 3. Inheriting this concept from 
previous chapter, we applied the same ultrasound conditions corresponding to the three 
basic categories of non-targeted microbubble to targeted microbubbles to see the 
similarity and differences between non-targeted microbubbles and targeted microbubbles. 
Figure 4-5 shows the targeted microbubbles response of ultrasound condition 0.06 
MPa, 20 hz PRF, 20% DC and 1 s exposure. When a strong binding existed between 
targeted microbubble surface and cell membrane, although the attraction was still built up 
between adjacent bubbles during ultrasound-on period, once ultrasound was off, bubbles 
moved back by the binding force on cell membrane (Fig.4-5B). This movement took 
place repeatedly driven by pulsed ultrasound (Fig.4-5B). In the case there was no bubble 
nearby, the binding force held targeted microbubble firmly during ultrasound exposure. 
No movement or very mild movement was observed (Fig.4-5C). When the binding with 
cell surface was weak, it can be broken during ultrasound, releasing targeted microbubble 
from the cell membrane. In this case, unbound targeted microbubbles performed just as 
non-targeted microbubble (Fig.4-5D and E).The bubbles shown in Fig.4-5C and D led PI 
uptake (Fig.4-5A). Linking on cell surface localized activated-bubble impact on cells.  
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Figure 4-5 A typical example of Targestar™-SA microbubbles behavior category 1: aggregation 
and microstreaming. In this example, Targestar™-SA microbubbles were conjugated with anti-
human CD31 antibody bound on HUVEC cells, excited by a 1.25 Mhz transducer, with 0.06 MPa, 
20 hz PRF, 20% DC (10ms in each pulse), 1 s exposure totally. Panel (A) shows selective bright 
field images of a 216 μm180 μm area before, during and immediately post ultrasound 
application, followed by fluorescence images excited at 538 nm before and post ultrasound for PI 
signals, and fluorescence images excited at 488 nm for calcein signal post ultrasound. Four sub-
areas are selected in Panel (A), labeled as (B-D). (B) and (C) are microbubbles, which were 
bound the cell surface though entire ultrasound exposure; while (D) and (E) are microbubbles, 
whose link to cell surface were broken during ultrasound exposure. More temporal information 
was shown in panel (B-D) accordingly. 
 
Driven by high acoustic pressure and long time (for the data shown in Fig.4-6, 
0.43 MPa, 10 ms ultrasound was applied), the link of targeted microbubble was 
disassembled quickly; therefore there is no significant difference between non-targeted 
and targeted microbubbles. Similarly to non-targeted microbubbles (Fig.3-3), detached 
small microbubbles first coalesced into big bubbles, and further fused into bigger 
bubbles. Fast translational movement associated with violent oscillation occurred with 
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the coalesced big bubbles. The bright field images (Fig.4-6) clearly shows that the cells, 
which encountered the fast moving bubbles, were either torn apart, squashed, deformed 
or detached from the bottom (Fig.4-6). 
 
Figure 4-6 A typical example of Targestar™-SA microbubbles behavior category 2: coalescence 
and translation. In this example, Targestar™-SA microbubbles were conjugated with anti-human 
CD31 antibody bound on HUVEC cells, excited by a 1.25 Mhz transducer, with 0.43 MPa, 10 ms. 
(All bubble disappeared immediately after ultrasound.) Panel (A) shows selective bright field 
images of a 216 μm180 μm area before, during and immediately post ultrasound application, 
followed by fluorescence images excited at 538 nm before and post ultrasound for PI signals, and 
fluorescence images excited at 488 nm for calcein signal post ultrasound. Panel (B) and (C) are 
sub-areas shown in the image of panel (A), with more temporal information, illustrating 
coalescence in (B) and newly fused big bubble fast translating while violently oscillating in (C).   
 
For the third category, high pressure, short pulse was applied (0.43 MPa, 10hz 
PRF, 0.008% DC (8 μs), 1s for the data shown in Fig.4-7) to the targeted microbubbles. 
Immediate disappear and shrink was observed  post each ultrasound pulse. The targeted 
microbubble may experience the similar dynamics during ultrasound-on time, as shown 
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in Fig.3-5 B-D. However, as these bubbles were positioned right on the cell surface, their 
collapse had more localized and maybe stronger impact on the cell membrane.  
. 
 
 
Figure 4-7 A typical example of Targestar™-SA microbubbles behavior category 3: collapse. In 
this example, Targestar™-SA microbubbles were conjugated with anti-human CD31 antibody 
bound on HUVEC cells, excited by a 1.25 Mhz transducer, with 0.43 MPa PNP, 10hz PRF, 0.008% 
duty cycle, 1s. Selective bright field images of a 293 μm233 μm areas before, during and post 1s 
ultrasound are shown followed by fluorescence images excited at 538 nm before and post 
ultrasound for PI signals, and fluorescence images excited at 488 nm for calcein signal post 
ultrasound. 
 
4.3.3 Delivery outcomes by sonoporation using targeted and non targeted 
microbubbles 
Under the same ultrasound parameters, quantified PI delivery outcomes were 
presented together in Fig.4-8 of non-targeted microbubbles in Opticell setting as 
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presented in Chapter 3 and targeted microbubbles in petri dish setting. For all three 
categories, PI delivery outcomes shared the same trends with non-targeted microbubbles 
in Opticell and targeted microbubbles in petri dish: “rapid collapse” provided the highest 
delivery efficiency among three categories; although targeted microbubbles in petri dish 
always had stronger effects than non-targeted microbubble in Opticell, killing more cells. 
Therefore “collapse” bubble dynamics mode was chosen for the following study.  
 
Figure 4-8 PI delivery outcomes of Definity® microbubbles (non-targeted microbubbles) in 
Opticell setting and Targestar™-SA microbubbles (targeted microbubbles) in petri dish setting in 
three typical categories: Cat.1: aggregation and microstreaming; Cat.2: coalescence and 
translation; and Cat.3: collapse. Ultrasound conditions used for data shown here for Definity® 
microbubbles are: Cat.1: 0.06 MPa, 20 hz PRF, 20% DC (10ms in each pulse), 1 s (N=9); Cat.2: 
0.43 MPa, 20 hz PRF, 20% DC, 1 s (N=10); and Cat.3: 0.43 MPa, 10 hz PRF,  0.008% duty cycle, 
1 s (N=13). Ultrasound conditions used for data shown here for Targestar™-SA microbubbles 
were the same as Definity® microbubbles: Cat 1 (N=6); Cat 2 (N=6); and Cat 3 (N=4). 
 
4.3.4 Optimization of PI delivery 
The ultrasound parameters creating the third category were 0.43MPa, 10hz PRF, 
0.008% DC (8μs), 1s, which was chosen arbitrarily. Starting from this ultrasound 
condition, we conducted systematic study to optimize delivery outcome using PI as the 
delivery indicator. This ultrasound condition led to 55%±10.3% cell death. If reduced the 
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pulse number applied, we may be able to increase the cell viability as well as delivery 
efficiency. As shown in Fig.4-9, as the pulsed number decreased from 10 pulses to 2 
pulses and further 1 pulse, the viability significantly increased as well as the delivery 
efficiency. 
 
Figure 4-9 Viability (A) and delivery efficiency (B) using PI as the delivery indicator with 
different ultrasound pulses. For all data, the acoustic pressure was 0.43MPa, 10hz PRF (for 
multiple pulses) and 8μs for each pulse. N≥5 for each condition.  
 
With 0.43MPa, one pulse generated better results than 2 pulses and 10 pulses; 
therefore one pulse ultrasound was applied for the following optimization. We applied 
different acoustic pressure with single ultrasound pulse to test whether with higher 
acoustic pressure, higher delivery efficiency and larger amount of PI can be resulted. PI 
intensity inside the cells were quantified and used as an indicator of PI amount delivered 
into the cells. The impacts of acoustic pressure on delivery outcome were shown in Fig.4-
10. 
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Figure 4-10 Viability (A), delivery efficiency (B) and PI intensity (C) with different acoustic 
pressure. For all data, single ultrasound pulse with 8μs duration was applied. N≥5 for each 
condition. 
 
Considering the plasmid used for gene transfection was much larger than small 
molecule PI, larger pore may be required. The acoustic pressure 1.6MPa, which led the 
highest PI intensity in these experiments: 20.1±2.9 (N=7) in arbitrary units at the cost of 
37%±5% cell death, was chosen for gene transfection experiments. 
When the situation that microbubbles attached on cell surface was created, 
another parameter that could take effect on delivery outcomes is the number of bubbles 
attached in each cell. It is found that when 2 or 3 bubbles attached per cell can induce 
higher delivery efficiency compared with 1 bubble attached case (Fig.4-11). As 
demonstrated in Fig.4-1, 2 bubble attachments can create 2 entry spots of PI, increasing 
the chance of extracellular agent uptake, which may explain why 2 or 3 bubble 
attachment had higher delivery efficiency than 1 bubble attachment. Although it’s hard to 
create a uniform bubble distribution on cells in entire FOV, by increasing targeted 
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microbubble density, a 2 or 3 bubbles per cell dominated situation can be generated. 
Therefore, for the following study, this bubble-cell ratio was adopted.  
 
Figure 4-11 Impact of the number of bubbles attached per cells (# bubble/cell) on delivery 
outcomes. (A-C) are typical example of # bubble/cell distribution 1 and (D-E) are typical 
example of distribution 2. (A) and (D) are calcein image superimposed bright field image before 
ultrasound. (B) and (E) are cell number grouped by # bubble/cell corresponding to the example 
shown in (A) and (D) in the entire FOV. Green, yellow and red represent surviving and no PI 
uptake cells, surviving and PI delivered cells and killed cells respectively. (C) and (F) convert the 
information shown in (B) and (E) into percentage within three groups (1bubble/cell, 2bubble/cell 
and 3bubble/cell).   
 
 
4.3.5 Enhanced gene transfection achieved by targeted microbubble and optimized 
ultrasound exposure condition 
For gene transfection, rat aortic smooth muscle cells (RASMC) were chosen, as it 
serves as an in vitro model to study sonoporation potential to treat cardiovascular disease. 
The presence of GFP 24 hours later is an indicator of successful gene transfection. To 
visualize plasmid, plasmid was fluorescently labeled using BOBO™-3 iodide. The 
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fluorescent image, which was taken right after ultrasound, shows that the plasmid was 
already homogeneously distributed in cytoplasm and nucleus (Fig.4-12A). Plasmid 
positive cells all had bubble attached before ultrasound (Fig.4-12C and D), indicating the 
rapid and direct transfer of plasmid by sonoporation probably via the physical pore in cell 
membrane. 
 
Figure 4-12 BOBO™-iodide labeled plasmid delivery was spatially correlated with bubble 
attached cells. (A) Fluorescent image excited at 570 nm post ultrasound. (B) Phase contrast bright 
field image post ultrasound. (C-D) are (A) superimposed with bright field image before and post 
ultrasound. Arrows point the bubbles, which resulted plasmid uptake. 
 
Based on the PI delivery study presented above, single ultrasound pulse consisting 
of 10 cycles (8μs duration) with 1.6 MPa was used to mediate gene transfection first. 
However, this parameter only resulted into 1.8 ±0.5% (N=9) transfection efficiency 
(Fig.4-15 G), which may be due to limited amount of plasmid delivered and some 
inherent obstacles on the gene expression pathway in RASMC. Fast speed bubble 
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dynamics recording revealed that after the 1
st
 ultrasound pulse, remaining bubbles did not 
disappeared right away (Fig.4-15D), which makes it possible to active bubble multiple 
times to generate multiple entry of plasmid. Therefore, 2 and 3 pulses with time interval 
0.05 s were employed. The lipid shell cracked or broke during the 1
st
 pulse; when the 2
nd
 
ultrasound pulse was arrived; residual bubbles were of smaller size, as shown in Fig.4-
13Dand F. To more effectively activate smaller residual bubbles, a scheme with ramped 
up acoustic pressure were employed, as illustrated in Fig.4-13G. The 2
nd
 pulse was with 
acoustic pressure 1.8 MPa, and the 3
rd
 pulse with 2.0 MPa. Two pulses ultrasound 
significantly increased the transfection efficiency compared with single pulse, leading a 
transfection efficiency 6.6±2.2% (N=9). While as three pulses may be too strong to cells, 
resulting severe cell death and unhealthy condition for the surviving cells, which may 
explain why the transfection efficiency dropped to 2.5±0.8% (N=4) with three pulses. 
Figure 4-14 presents a typical image of GFP expression using two pulses with ramped up 
pressure ultrasound scheme. 
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Figure 4-13 Characterization of bubble number and bubble size change in three ultrasound 
conditions: 1.6 MPa, 8 μs (A and B); 1.6 MPa, 8 μs followed by 1.8 MPa, 8 μs with 50 ms time 
interval (C and D); and 1.6 MPa, 8 μs, followed by 1.8 MPa, 8 μs, and 2.0 MPa, 8 μs with 50 ms 
time interval (E and F). (G) Gene transfection efficiency corresponding to the three conditions, 
and from lipofection (purple filled bar).  
G 
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Figure 4-14 Example images show GFP expressed cells (A) and superimposed with bright field 
phase contrast image (B) using ultrasound condition: 1.6 MPa, 8 μs followed by 1.8 MPa, 8 μs 
with 50 ms time interval. 
 
4.4 Discussion 
4.4.1 Controlled ultrasound excitation of targeted microbubbles 
By incorporating ligands in the microbubble coating materials, microbubbles can 
achieve localized adhesion at the site where a specific molecular marker is expresses, 
which is the underlying mechanism for ultrasound molecular imaging and therapy. The 
close distance between microbubble and cell surface significantly increase the 
vulnerability of cell membrane to microbubble action upon ultrasound excitation. Thanks 
to the superior controllability provided by targeted microbubbles, we demonstrated that 
multiple entry areas and multiple excitations, as well as selectively excitation of targeted 
microbubbles. The response of a microbubble to ultrasound excitation (cavitation), such 
as expansion, contraction and collapse, depends on the size of the bubble and the acoustic 
parameters including the acoustic pressure, center frequency, and pulse duration [12, 
100]. For preformed microbubbles with a thin encapsulating shell, the ultrasound driven 
expansion and contraction of the bubble often destroy the protecting shell [193], resulting 
in more robust volume oscillation and/or collapse of the free gas bubble. The oscillation 
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and collapse of the bubble are in the time scale below sub-µs for ultrasound excitation in 
the MHz frequency. Ultra-fast video-microscopy [12, 13] (millions frames/s) has 
illustrated some details of cavitation including the formation of membrane-directing fluid 
jet during violent bubble collapse near a cell membrane. In this study, we presented ultra-
fast images of Definity® microbubble oscillation in OptiCell™ with different initial 
bubbles size to demonstrate the concept that at the same acoustic pressure, larger 
microbubbles exhibits larger expansion during ultrasound rarefaction. All the 
microbubbles were linked on the cell surface, and the distances were reported much less 
than 100 nm [182], which is almost negligible compared with micron scale microbubbles 
and its even bigger expansion size, thereby larger expansion will result larger 
deformation of the cell membrane, leading more agent uptake. As the fundamental causes 
for any sonoporation outcomes, microbubble interaction with cells under ultrasound 
exposure is the key to gauge the effect of ultrasound application. 
4.4.2 Binding force between targeted microbubbles and cell membrane 
Both for the application of molecular imaging and targeted drug delivery, it is 
essential of targeted microbubbles to form stable and firm bonds with cell surface. In this 
study, we observed that under ultrasound condition of 0.06 MPa, 20 hz PRF, 20% DC, 1 
s, some microbubbles exhibited very firm bonds on cell surface, that they moved a couple 
of micron away from their initial position during ultrasound-on time, and restored back 
during ultrasound-off time, and it occurred repeatedly (Fig.4-5B); while some 
microbubbles were released from broken bonds (Fig.4-5D and E), which indicates the 
strength of the binding varies from bubble to bubble.  
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The AFM result suggested that the single bond formed between CD31 antibody, 
which was decorated in microbubble via biotin-avidin link, and CD31 expressed on Sk-
Hep1 hepatic endothelial cells had a median of 93 pN adhesion force [194]. The total 
binding force between a single microbubble and cell membrane also depends on ligand 
density of microbubble surface, receptor availability of cell membrane and the contact 
area, which may vary dramatically from case to case. That’s why we see different 
situations of disassociation between microbubbles and cell membrane under the same 
ultrasound influence. Our observation also demonstrated that both the first and secondary 
radiation force (Fig.4-5D) can be used as an energy modality to detach microbubbles 
from cell surface. Secondary radiation force has been employed to estimate the force 
between single bond to be hundreds of pN [182].  
4.4.3 Restoring and detachment mechanisms  
In this study, we observed both restoring after microns displacement and 
detachment of targeted microbubbles when driven by mild ultrasound (Fig.4-5B-E). The 
mechanisms for the restoring force is suggested to be deformation of microbubbles or 
lipid bilayers of cell membrane [182, 194], or excess interfacial materials to form tethers 
and folds extending outward [72, 195] , and it is less likely to the springs behavior of 
ligand and receptor [196], as this distance was at sub-nanometer scale and therefore 
cannot account for the micron scale displacement observed in this study. When the 
pulling force exceeds the strength of the total binding force between microbubbles and 
cell surface, detachment will happen. Most likely the break occurred first between ligand 
and receptor [194] and  less likely occurred first between avidin and biotin, as it’s 
reported to have a larger binding force around 257 pN [197]. 
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4.4.4 Loading capability of antibody on microbubbles 
Currently, the relative low antibody density carried in microbubble is one limiting 
factor in forming strong bonds. It is reported that CD31 molecules expressed in 
endothelial cell was at the level of 10
6
 molecule/cell [198]. Based on the images show in 
this study, the cell surface area is around 2100 μm2; therefore, the receptor density is 
5103 molecule/μm2. The contact area was estimated to be 1 μm2 [88]. With current 
technique, antibody linked on microbubbles was approximately 100-200 molecule/ μm2 
[88, 182]. As a result, in the contact area, receptors are in one order more than antibody 
and exceed even more in the case where receptors are over expressed under pathological 
condition. Therefore, great efforts have been made to enhance the load capability of 
antibody on microbubbles. With more sophisticated strategies, therapeutic reagents can 
also be coupled on microbubbles, which will further enhance the targeted delivery 
efficiency [3, 12, 67, 72, 190, 199] 
4.4.5 The impact of primary radiation force and ratio of bubble/cell on delivery 
outcomes  
Figure 4-11 presents the PI delivery outcomes using the same ultrasound 
parameters with non-targeted microbubble (Definity® in Opticell setting) and targeted 
microbubbles (Target-start SA in petri dish setting). The data shows that with targeted 
microbubbles, it always generated stronger impacts on cell, meaning killing more cells 
than with non-targeted microbubbles. The close distance between targeted bubble and 
cell surface may contribute to the stronger impact. However, given the configuration of 
cells and bubbles were different in two settings, other factors, such as primary radiation 
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force and ratio of bubble/cell may also be responsible for the delivery outcomes 
difference and should be taken into consideration. 
 
Figure 4-15 Schematic illustration of the direction of primary radiation force in Opticell setting 
with Definity® microbubbl (A) and in petri dish setting with Targestar™-SA targeted 
microbubble (B). 
 
As shown in Fig.4-15, in Opticell, when ultrasound was applied, the primary 
radiation force was pushing microbubble away from cell surface, while in petri dish 
setting, when ultrasound was applied; the primary radiation force was towards cells. This 
may be partially responsible for the stronger impact resulted in petri dish setting. We 
estimated primary radiation force under ultrasound condition creating basic category one 
and compared it with buoyancy. Once the Definity microbubble was pushed away from 
cell monolayer during ultrasound on, it was subject to buoyancy and primary radiation 
force only (Fig.4-16). 
 
Figure 4-16 Force diagram of Definity® microbubble once it was pushed away from cell 
monolayer.  
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Under the assumption of small-amplitude linear oscillation, and the time averaged 
primary radiation force exerted on microbubbles were estimated using the following 
equation [112] 
       
        
    
   
     
       
{[         ]
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                                       Equ. 4-1 
where    is incident acoustic pressure amplitude,  is duration of each transmitted 
pulse,  is pulse repetition period,   is bubble radius at equilibrium,   is density of 
surrounding medium,   is frequency (radians/second),    is resonant frequency of the 
bubble,      is dimensionless damping coefficient related to      by               
,       is total damping costant, includes dissipation due to radiation, viscoelastic and 
thermal losses. 
To calculate the resonant frequency of Definity® microbubble with equilibrium 
radius  , Equation 4-2 was used, cited from Goertz etc [200] 
   
 
  
√
    
    
 
   
    
                                                        Equ. 4-2 
Where   is the polytropic exponent,   is the bubble radius at equilibrium,   is 
density of surrounding medium,    is the ambient pressure (100 kPa), and    is the 
stiffness of shell.  
The total damping constant (    ) is the sum of the radiation (    ), viscous 
(    ), and shell friction (   ) terms. To calculate the       , the following four equations 
were used [200]: 
                                                                     Equ. 4-3 
     
  
 
                                                                                    Equ. 4-4 
     
   
     
                                                 Equ. 4-5 
   
  
       
                                                                         Equ. 4-6 
Where    is the liquid viscosity and    is the viscosity of the shell. 
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In this study, we used Definity® microbubbles and the surrounding medium can 
be considered as water. The ultrasound condition for category 1 (0.06MPa, 20hz PRF, 20% 
duty cycle, 1s) satisfied the assumption of small-amplitude linear oscillation. Therefore 
Equ.4-1 to 6 was used to estimate the force exerted on a Definity® microbubble (Fig.4-
17). The primary radiation force has a peak with 4.25μm radius Definity® microbubble 
(Fig.4-17B), as the incident ultrasound has the center frequency of 1.25Mhz, which is the 
resonance frequency of a 4.25μm radius Definity microbubble (Fig.4-17A). The primary 
radiation force is significantly larger than Buoyancy (Fig.4-17B-C). For example, a 
Definity® microbubble with radius 2.5μm, primary radiation force exerted on it is 
1.8510-11 N while buoyancy on it is 6.4110-13 N, 2 orders higher. Therefore, primary 
radiation force is an important factor that contributes to stronger impact of the same 
ultrasound conditions in petri dish setting compared with Opticell setting.   
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Figure 4-17 Simulation of resonance frequency of Definity® microbubbles (A), time-averaged 
primary radiation force on a Definity® microbubble with 0.06MPa peak negative pressure and 20% 
DC (B) and buoyancy of Definity® microbubbles in water. 
 
Another factor that may affect the delivery outcomes due the configuration 
difference in Opticell and petri dish is the ratio of bubble per cell.  Under the ultrasound 
condition: 0.43MPa, 10hz PRF, 0.008%DC (8μs), 1s, which generated the third basic 
bubble dynamics category, the ratio of bubble per cell in Opticell with Definity® was 
6.2±0.9 bubbles/cell (N=9); and in petri dish with targeted microbubble, it was 2.2±0.4 
bubble/cell (N=4). In Opticell, the ratio was calculated by dividing the total bubbles 
number in FOV by the total cells number in FOV. In petri dish with targeted 
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microbubbles, a histogram of bubble/cell was generated first, as it was clear how many 
bubbles attached to individual cells. Then an average was calculated to present the mean 
ratio of bubble/cell in this data. 
Cells subjected to more bubbles in Opticell did not lead to a stronger delivery 
outcomes than in petri dish with targeted microbubbles. This may be explained as 
bubbles were under stronger influence of secondary radiation force with higher density; 
or in Opticell bubbles preferably located in the cell edge area, as edge is vertically higher 
than the nucleus area. In addition, the difference in the construction and chemical 
composition of Definity® microbubbles and Targestar™-SA microbubbles may also 
contribute to their different responses to ultrasound and therefore the difference in 
delivery outcomes. 
In short, based on the study with Definity® microbubble in Opticell and 
Targestar™-SA microbubble in petri dish, no conclusions can be made about whether 
non-targeted microbubbles or targeted microbubble have stronger impact on cells under 
the same ultrasound conditions, as many differences involved in these two sets of 
experiences, such as the direction of primary radiation force, the ratio of bubble/cells, the 
difference between two bubble types, etc.   
4.5 Conclusion 
Ligand-conjugated microbubbles showed favorable for controlled intracellular 
delivery. Based on in-depth understanding of ultrasound-driven microbubbles dynamics 
in sonoporation process, we achieved enhanced gene transfection efficiency, 6.6% to 
RASMC compared to the 1% efficiency to RASMC reported in literature using 
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sonoporation[67].This well controlled platform has a promising perspective to extend its 
applications into boarder biological and biophysical research context.     
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Chapter 5  
Future Work 
In this thesis work, we studied the transmembrane delivery and calcium transients 
generated by sonoporation (Chapter 2), investigated the critical role that ultrasound-
driven microbubbles play in sonoporation and the resulting intracellular delivery, and 
achieved improved gene transfection using targeted microbubbles and optimized 
ultrasound exposure conditions (Chapter 3 and 4). The results obtained from this study 
provide new insights into the cellular and biophysical aspects of sonoporation, which can 
be helpful in the effort to develop sonoporation as a reliable and robust technique for 
intracellular delivery applications.   
Introducing ion exchange while delivering extracellular agent is a special feature 
in sonoporation compared with other delivery methods, such as lipofection, as 
demonstrated in Chapter 2. Intracellular ion concentration change is very important, 
especially to excitable cells, such as cardiomyocyte and neurons. For the future, we 
propose to create controlled ion influx by sonoporation to manipulate the transmembrane 
potential in excitable cells. We achieved 92% delivery efficiency of PI and 6.6% gene 
transfection to RASMC using targeted microbubbles under optimized ultrasound 
conditions based on comprehensive understanding of bubble dynamics in Chapter 3 and 
4. However, the gene transfection efficiency is still far from being ideal. Successful 
delivery of plasmid into cell is the first step leading to gene transfection. The limiting 
factors may exist in the following intracellular migration and expression pathways of 
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delivered plasmid. Therefore, to further understand and improve gene transfection 
efficiency, for the future work, we propose to study the internalization and expression 
pathways of exogenous plasmid after sonoporation.   
5.1 Specific topics for future investigations 
5.1.1 Manipulation of the contraction rhythm of cardiomyocyte via controlled Ca
2+
 
influx by sonoporation 
In this study, we demonstrated the Ca
2+
 influx was generated after cell membrane 
sonoporated. Ca
2+
 plays an important role not only in cell communication, but also in 
regulating cell membrane voltage [201-203]. Therefore, another potential consequence of 
Ca
2+
 influx along with other ion influx through the pore can be membrane voltage 
change, which can be used to manipulate excitable cells, such as cardiomyocyte and 
neuron. Automatic rhythmic contraction is the unique property of cardiomyocytes, and 
Ca
2+
 play an important role in contraction regulating [204-206]. By attaching targeted 
microbubble on cardiomyocyte surface, and stimulating it periodically, potentially we 
could induce Ca
2+
 ion into cardiomyocyte periodically, therefore manipulate the 
membrane voltage and change its contraction rhythm. Premature cardiac contraction 
(arrhythmias) has been reported in laboratory animals and human during contract agent 
enhanced echocardiography [137, 174, 175]. The study proposed here could uncover the 
mechanisms for observed premature contraction and also potentially lead the 
development of a sonoporation based arrhythmias treatment strategy. Figure 5-1 presents 
the preliminary results demonstrating the feasibility of changing the contraction rhythm 
of cardiomyocyte. 
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Figure 5-1 A example demonstrates that contraction rhythm of cardiomyocyte was changed by 
ultrasound application in the presence of microbubbles. (A) Bright field image before ultrasound 
of a group of cardiomyocytes clustered together attached on the upper inner membrane of 
Opticell. Some of the black circles were Definity® microbubbles, such as the ones pointed by 
arrows. The area within the frame was selected to monitor the contraction. The zoomed area is 
shown on the right side of the image. The black small area in the center of this frame was traced 
and analyzed using Matlab. Its displacement relative to its original position at time 0 as a function 
of time was plotted in (B). A single ultrasound pulse with 0.43MPa peak negative pressure and 
8μs duration was applied at time 10s.    
 
5.1.2 Study of gene internalization and expression pathways in sonoporation  
The 6.6±2.2% (N=9) transfection efficiency of RASMC is encouraging, and 
comparable with lipofection result, 7.5±0.8% (N=9). However, the gene transfection 
efficiency is still considered low compared with the virus mediated transfection. 
Ultrasound application facilitates plasmid transporting across cell membrane. After 
entering cytoplasm, there were many intermediate steps before the protein, which the 
plasmid encodes, eventually expressed, such as the migration of plasmid from cytoplasm 
towards nucleus, transportation across nucleic envelope, and expression of plasmid, etc. 
Obstacles may exist in these pathways. Therefore, to further understand and improve 
gene transfection efficiency, it’s of great importance to reveal the internalization and 
expression pathways of exogenous plasmid after sonoporation. Figure 5-2 shows the 
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preliminary work we have done, showing that gene uptake manner and fate of exogenous 
plasmid inside the cells are different in sonoporation and lipofection. It is well known 
that in lipofection endocytosis is the plasmid uptake mechanisms. In this preliminary 
study, we labeled the plasmid with BOBO™-3 iodide as described in Chapter 4.  
Although the BOBO-plasmid signal was strong and evenly distributed throughout 
the cell right after ultrasound (Fig.5-2 A) indicating a rapid and efficient physical route 
was created by ultrasound application to transport plasmid across cell membrane. 
However, 24 hours later, BOBO-plasmid fluorescent signal disappeared completely 
(Fig.5-2 B). In contrast, in lipofection BOBO-labeled plasmid still can be seen clearly 24 
hours later (Fig.5-3 C). Moreover, in lipofection BOBO-labeled plasmid fluorescent 
signals were clustered in many small spots, which perfectly matched with vesicle 
structure shown in phase contrast bright field, suggesting that the plasmid was transferred 
via endocytosis and were still confined in endocytic vesicles 24 hours later. After 
sonoporation, however, vesicle structure was not observed at all in phase contrast bright 
filed images, indicating endocytosis was not involved in sonoporation. This preliminary 
result is consistent with other studies visualizing plasmid kinetics in sonoporation [3, 40]. 
For the future work, live cell imaging can be applied to continuously monitor the plasmid 
change in cytoplasm as well as the GFP expression dynamics.  
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Figure 5-2 BOBO-labeled plasmid distribution 30minutes after sonoporation (A), and 24 hours 
after sonoporation (B) of the same area; and 24 hours after lipofection (C). 
   
5.1.3 Microbubbles patterning and spatially defined delivery by incorporating 
aqueous two phase system (ATPS) with sonoporation 
 To precisely control microbubbles location in this thesis work, we took 
advantage of the ligand-receptor binding used in targeted microbubbles. However, to 
reach 10 μg/ml plasmid concentration, a large amount of plasmid was needed to dissolve 
in the extracellular medium, which is not a regent efficient manner, wasting a lot of 
expensive material, such as plasmid; and to bind targeted microbubbles onto cell 
membrane, a protocol including flipping the dish was applied, which is inconvenient and 
could introduce uneven binding outcomes if the dish is slight tilt during facing down 
period. We can solve all these problems if we can confine the microbubbles as well as 
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plasmid in a small volume right on top of cell membrane. Aqueous two-phases systems 
(ATPS) have been demonstrated as a successful method to deliver genetic materials to 
mammalian cells using liquid patterning of droplets containing only hundreds of nanoliter 
liquid [207]. With modified formula, it’s possible to generate picoliter droplet confining 
microbubbles covering a surface with attached cells. Because of the picoliter volume, the 
interface of two phases will be very close to cell surface, so that microbubbles can 
contact cell membrane without flipping over dishes. In the meantime, the reagents for 
delivery, such as plasmids, can be mixed and confined in the picoliter droplet as well, 
providing cell-reagent efficient condition and resulting 0.01 mm
2
 level spatially defined 
delivery outcomes by sonoporation. The concept is illustrated as illustrated in Fig.5-3. 
 
Figure 5-3 Illustration of picoliter microbubble patterning and spatially defined delivery 
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